Special tissues, cell organelles and inclusions
Robyn Siebert and John Stirling

Pancreas: islets of Langerhans
STRUCTURE AND FUNCTION
The pancreas is an elongate, mixed exocrine and endocrine gland that lies adjacent to the duodenum; it is divided into head, body and tail regions.

The exocrine pancreas, the larger component (98-99%), is composed of tubulo-acinar glands that empty, via a highly branched duct system, into the main pancreatic duct. This duct runs the entire length of the gland and opens into the duodenum through the ampulla of Vater. The acinar cells produce digestive enzymes, and some duct lining cells yield fluid rich in sodium and bicarbonate1.

The endocrine pancreas (1 to 2% of the adult pancreatic mass2) comprises the islets of Langerhans and some scattered cells that occur singly or in small groups3. These are distributed throughout the exocrine pancreas, although the islets are more numerous in the tail1. Endocrine cells are also found within the ductal system3. In haematoxylin and eosin stained sections the islets appear as rounded, compact groups of pale staining cells, with a rich blood supply. However, some islets in the posterior region of the pancreatic head are more irregular in shape, with large elongate cells arranged in trabeculae2.

Human islet cells have been classified as four types based on their hormone production: A (glucagon); B (insulin); D (somatostatin); and PP (pancreatic polypeptide)4,5. The relative frequency and distribution of the cell types within islets are given in Table 1. In the special islets of the pancreatic head the proportion of PP cells is increased2 whilst the endocrine cells found outside the islets include both PP and D cells3. Two other cell types occur infrequently: D1 cells that secrete vasoactive intestinal peptide (VIP) and enterochromaffin cells that secrete serotonin5.

PATHOLOGY
The most common significant clinical disease of the endocrine pancreas is diabetes mellitus. Associated morphological changes in the islets are not a consistent nor diagnostic feature of diabetes but may include: variation in the size and number of islets; variation in the A:B cell ratio; B cell degranulation; fibrosis; amyloid deposition; and leucocytic infiltration5. Cell numbers and the A:B cell ratio can vary in chronic pancreatitis and some other clinical and experimental conditions3.

The most important lesions in terms of morphological and histochemical examination of the endocrine pancreas are the relatively uncommon islet cell tumours. These can arise in any region of the pancreas as single or multiple lesions composed of one or more cell type. Such tumours can be benign or malignant and may produce hormones of pancreatic or non-pancreatic origin at significant levels. The most common presentations are associated with:

· ß-cell tumour (insulinoma) - hyperinsulinism and hypoglycaemia;
· gastrinoma - Zollinger-Ellison syndrome; and
· multiple endocrine neoplasia - including tumours or hyperplasias of other endocrine glands.

A-cell tumours (glucagonomas), D-cell tumours (somatostatinomas), VIP-omas, pancreatic carcinoid tumours and PP-cell tumours are rare5. Islet cell tumours which produce more than one hormone are categorised according to the predominant hormone6. However, this classification does not always correlate with the clinical symptoms, and the secretory pattern of multihormonal tumours can sometimes change with time7 or following chemotherapy3. Since these tumours can also produce hormones of non-pancreatic type, accurate identification of cells and their hormone production is important to determine appropriate therapy and follow-up investigations6.

SPECIMEN PREPARATION
To obtain accurate information on the structure and function of the endocrine pancreas multiple samples must be taken from different regions because of the variable distribution of cell types in both normal and pathological conditions4. When this is not possible accurate documentation as to the site of the biopsy is required2.

Rapid fixation preserves the hormone content and in-situ localisation, but if delay is unavoidable the tissue should be held at 4°C. Bouin's fluid is the preferred fixative for routine haematoxylin and eosin, histochemical and immunocytochemical techniques4 but 10% neutral buffered formalin is also suitable.

STAINING
The different cell types of the endocrine pancreas cannot be distinguished in haematoxylin and eosin stained sections, but a number of histochemical methods allow some differentiation. Unfortunately, these techniques are not sufficiently sensitive, specific nor reliable to use in the definitive classification of islet cell tumours as they do not provide information on the hormone production of the cells. However, histochemical techniques are useful for the initial examination, to demonstrate cell types (primarily A and B cells) and to aid selection of antisera for immunocytochemical studies4. The most appropriate histochemical methods are Gomori's aldehyde fuchsin (AF) for B cells and the Grimelius argyrophil technique for A and other endocrine cells4. Immunocytochemical techniques, using specific antisera against the various hormones produced by islet cell tumours, are required to accurately determine the functional capacity of these tumours. Other useful techniques include: chrome alum haematoxylin-phloxine for A and B cells8; phosphotungstic acid haematoxylin for A cells9; lead haematoxylin for A, D and other endocrine cells8 and; combined argyrophil, AF and lead haematoxylin for demonstration of A, B and D cells in a single section10. The different cell types can also be identified according to the ultrastructural morphology of their secretory granules11.

GOMORI'S ALDEHYDE FUCHSIN
In 1950 Gomori12 described an 'aldehyde fuchsin' staining technique that demonstrated elastic fibres, mast cell granules, gastric chief cells, pancreatic islet B cells, some basophils of the anterior pituitary and some mucins. Despite numerous investigations the mechanism of AF staining of pancreatic islet B-cell granules has not been conclusively determined,13,14,15 but differs between oxidised and unoxidised sections. Mowry16,17 detailed three types of AF reactions:

· staining of sulphated and carboxylated tissue polyanions (mast cell granules, acidic mucins) as occurs with other basic (cationic) dyes, such as Alcian Blue;
· staining of polyaldehydes produced in tissue by oxidation of poly-vic-glycols (glycogen, epithelial mucins);
· reaction with certain non-ionic proteins and polypeptides rich in cystine, without prior oxidation (pancreatic islet B-cell granules, elastic fibres).

This third reaction type describes the unique property of AF solutions when applied to unoxidised tissue sections; prestaining of tissue polyanions with Alcian Blue has been advocated to increase the selectivity of the subsequent AF staining16,17 AF is thought to bind to the membrane of the B-cell granule rather than the granule contents (insulin and proinsulin) in unoxidised sections18,19,20. In oxidised sections the cystine-rich substances are rendered acidic (anionic) and stain with basic (cationic) dyes16.

A number of factors affect the staining of pancreatic B-cell granules with AF12,16,17,21:

Fixation
Fixation must be prompt and sufficient to prevent dissolution of the insulin-containing B-cell granules in the acid-ethanol solvent of the AF solution. Thorough fixation (at least 24 hours) in formalin or Bouin's solution is recommended as these fixatives provide a clear background. Mercury-containing fixatives produce a pale lilac background, whilst those containing dichromate produce murky staining and should be avoided.

Oxidation
Gomori noted that more rapid and intense staining was obtained with AF after iodine/sulphite treatment. Scott22 used permanganate (a stronger oxidant) to decrease staining times further and to increase staining intensity, but selectivity is also decreased as other tissue components are altered by oxidation. Without prior oxidation staining times of up to 4 hours may be required to achieve comparable results, depending upon the age of the AF solution.

Basic fuchsin
This is a mixture of Pararosaniline, Rosaniline and other dye homologues. The Pararosaniline component (CI 42500) is responsible for staining pancreatic B-cell granules in unoxidised sections.

The aldehyde
Gomori found, after using different aldehydes when preparing AF, that paraldehyde gave the best results. A more recent study23 has concluded that only paraldehyde and acetaldehyde are effective for AF staining of unoxidised pancreatic B-cell granules. Paraldehyde must be fresh and is best obtained in small volumes or aliquoted and stored at 4°C. Some protocols use 3% paraldehyde which reportedly gives stronger staining.

Ripening of AF
It is widely accepted that the ripening of AF at room temperature requires at least two to three days for useful staining and up to five days to eliminate all background staining. The time may be decreased by heating the solution.

Shelf life of AF
The useful life of AF solutions is prolonged by storage at 4°C, but the preparation should be brought to room temperature before staining. The precipitate that forms during storage can be removed by rapid filtration or centrifugation, although repeated treatments will decrease the potency of the staining solution. The capacity for staining elastic fibres is retained longer than pancreatic B-cell granules. If AF staining is performed routinely, variability is reduced by maintaining a fresh solution that should be replaced regularly (monthly)24. Otherwise as the solution ages, staining times may need to be increased. Dried powder forms of AF that are reconstituted for use give inferior staining results to those obtained with conventionally prepared AF solutions14,21.

Modified Gomori aldehyde fuchsin25
SPECIMEN PREPARATION
Cut 3 to 5 µm thick paraffin sections from tissue fixed in Bouin's fluid or 10% neutral buffered formalin. Pancreas is recommended as control tissue.

REAGENTS REQUIRED
1 Lugol's iodine
2 5% aqueous sodium thiosulphate
Sodium thiosulphate 5 g
Distilled water 100 ml
3 Aldehyde fuchsin
Pararosaniline (CI 42500) 0.5 g
70% ethanol 100 ml
Paraldehyde 1 ml
Concentrated hydrochloric acid 1 ml
Dissolve the pararosaniline in the ethanol. Add the paraldehyde and hydrochloric acid. Allow to ripen at room temperature in the dark for 3 to 5 days then store at 4°C.
4 Light green/orange G
Light Green SF Yellowish (CI 42095) 0.2 g
Orange G (CI 16230) 1 g
Phosphotungstic acid 0.5 g
Distilled water 100 ml
Glacial acetic acid 1 ml
Mix in the proportions indicated. This stain keeps well at room temperature.
5 Celestin blue/alum haematoxylin

METHOD
1 Dewax and rehydrate sections.
2 Place sections in Lugol's iodine for 30 minutes.
3 Wash in water.
4 Decolourise with sodium thiosulphate for 2 minutes.
5 Wash in water.
6 Rinse in 70% ethanol.
7 Immerse sections in aldehyde fuchsin staining solution for 15-30 minutes. Check staining microscopically (see note 3).
8 Rinse in 95% ethanol.
9 Wash in water.
10 Stain nuclei with celestine blue/alum haematoxylin, differentiate and blue.
11 Rinse in distilled water.
12 Counterstain with light green/orange G for 45 seconds.
13 Rinse briefly in 0.2% acetic acid, then in 95% ethanol.
14 Dehydrate, clear and mount.

RESULT
Nuclei - blue/black
B-cell granules - purple
A-cell granules - yellow
D-cell granules - green
Collagen - green
Mast cells, elastic fibres and some mucins - purple

TECHNICAL NOTES
1 For direct AF staining (no oxidation) omit steps 2 to 5 (above) and increase the AF staining time (step 7) as necessary.
2 When using Scott's permanganate oxidation replace the iodine/thiosulphate treatment (steps 2 to 5, above) as follows:
Step 2. Oxidise sections in a mixture of equal parts of 0.5% potassium permanganate and 0.5% sulphuric acid for 2 minutes.
Step 3. Rinse in water.
Step 4. Decolourise in 2% sodium bisulphite until the section appears white.
Step 5. Wash well in water for 2 minutes.
3 AF staining must be monitored microscopically as it progresses. Rinse slides in 95% ethanol, examine microscopically and replace in the staining solution until the desired staining is obtained.
4 Alternative counterstains include: the Grimelius argyrophil technique17,26,27 and Gomori's phloxine28.

THE GRIMELIUS ARGYROPHIL TECHNIQUE26
In 1968 Grimelius described an argyrophil technique to demonstrate A (or a 2)29 cells of the pancreatic islets, in formalin or Bouin's fixed tissue. This technique can be used as a general method for endocrine cells (particularly those found scattered through the exocrine pancreas26 and in the gastrointestinal tract27) and is of value in identifying endocrine tumours that show atypical morphology on light microscopy7. The glucagon component of A-cell granules is not demonstrated30 but rather the argyrophilia corresponds to the presence of chromogranin A, a granular protein31. The B and D cells of the endocrine pancreas are not demonstrated by this method4. The original technique (variant II)26,27 requires silver impregnation at 60°C for 3 hours, but this time can be reduced using microwave irradiation (15 minutes)32,33 or by preheating the silver and reducing solutions (10 minutes)34. A one-step combined silver and reducing solution method (25 minutes, microwave 5 minutes) has also been described35.

SPECIMEN PREPARATION
Cut 3 to 5 µm thick paraffin sections from tissue fixed in 10% neutral buffered formalin or Bouin's fluid. Fixatives containing ethanol, mercuric chloride, dichromate or osmium should not be used36. Pancreas is recommended as control tissue.

REAGENT PREPARATION
1 0.2 mol/l acetate buffer, pH 5.6
a) 1.2% acetic acid
Glacial acetic acid 1.2 ml
Distilled water 100 ml
b) 1.64% sodium acetate
Sodium acetate anhydrous 1.64 g
Distilled water 100 ml
Mix 4.8 ml of solution a) and 45.2 ml of solution b).
2 Silver nitrate solution
0.2 mol/l acetate buffer, pH 5.6 10 ml
Distilled water 87 ml
1% aqueous silver nitrate 3 ml
3 Reducing solution
Hydroquinone 1 g
Sodium sulphite 5 g
Distilled water 100 ml
4 Kernechtrot
Kernechtrot (Nuclear Fast Red CI 60760) 0.1 g
Aluminium sulphate 5 g
Distilled water 100 ml
Dissolve with heat. Cool and filter.

METHOD
1 Dewax and rehydrate sections.
2 Place slides in silver nitrate solution at room temperature and then incubate at 60°C for 3 hours.
3 Drain slides and place in freshly prepared reducing solution at 40-45°C for 1 minute.
4 Rinse in distilled water.
Note: A weak argyrophil reaction can be enhanced by double impregnation:
a) Place slides in 5% sodium thiosulphate for 2 minutes.
b) Wash slides in distilled water for 5 minutes.
c) Place in freshly prepared silver solution at room temperature for 15 minutes.
d) Drain slides and place in freshly prepared reducing solution at 55°C for 1 minute.
e) Rinse in distilled water.
5 Counterstain nuclei with Kernechtrot, if desired.
6 Rinse rapidly in distilled water.
7 Dehydrate, clear and mount.

RESULTS
Argyrophil granules - black
Nuclei - red

TECHNICAL NOTES
1 To intensify the reaction when demonstrating argyrophil cells of the gastrointestinal tract increase the silver nitrate concentration to 0.07% and the temperature of the reducing solution to 55°C27.
2 Distilled water rinses between the impregnation and reducing solutions reduce the non-specific yellow background staining34.
3 The yellow background staining usually enables tissue orientation.

Pituitary
The pituitary gland (or hypophysis) lies centrally at the base of the brain in a depression in the floor of the cranial cavity. It is attached to the hypothalamus via the infundibulum and consists of two main lobes, designated anterior and posterior according to their anatomical positions. These two lobes are developmentally, structurally and functionally distinct.

Anterior pituitary
STRUCTURE AND FUNCTION
The anterior lobe (or adenohypophysis) is the glandular portion, composed of nests and cords of cells within an interlacing network of small capillaries. The cells of the anterior pituitary produce growth hormone (GH), prolactin (PRL), adrenocorticotrophic hormone (ACTH), melanocyte stimulating hormone (MSH), b -lipotropin (b -LPH), follicle stimulating hormone (FSH), luteinising or interstitial cell stimulating hormone (LH or ICSH) and thyroid stimulating hormone (TSH). Secretion is regulated by 'releasing' and 'inhibiting' factors produced in the hypothalamus and transported to the anterior lobe via the hypophyseal portal veins. A negative feedback system controls the secretion of these factors37.

SPECIMEN PREPARATION
Pituitary tissue must be fixed promptly to prevent the diffusion and/or loss of hormones, a problem that occurs when interruption to the blood supply is prolonged or the gland is traumatised during removal38. Post mortem specimens should be collected within 4 hours of death39. Fixation in 10% neutral buffered formalin preserves morphological detail and retains hormones in situ, but for specific staining techniques other fixatives are recommended40,41,42.

The gland should be sectioned in the horizontal plane for optimal examination of the medial 'mucoid' wedge and lateral 'acidophil' wings of the anterior lobe. This enables evaluation of the distribution and relative frequency of the different cell types38.

STAINING
Three cell types (acidophils, basophils and chromophobes) can be identified in thin haematoxylin and eosin stained sections as their respective secretory granules have differing affinities for acidic and basic dyes1,43 (Table 1) although some simple special stains will give improved cellular differentiation (Table 2). Other techniques allow basophils to be separated into two subtypes (Table 3), and when this information is combined with morphological criteria and the pattern of cell distribution, three or more subtypes can be identified. Unfortunately, some of these methods are complex and require experience to obtain good quality, consistent staining results. Those which use a strong oxidising agent (especially performic acid) can also disrupt tissue and result in section loss42. Acidophils can be divided into two subtypes by selective staining of prolactin producing cells48 using either Herlant's erythrocin stain41 or Brooks' carmoisine technique44. The orange G-acid fuchsin-light green (OFG) method of Slidders40 is a suitable routine stain for the differentiation of acidophils, basophils and chromophobes, and the architectural pattern of the gland is well demonstrated with a reticulin stain43. A control section of normal pituitary should always be stained in parallel with the test case to allow comparison with normal morphology and cell distribution38.

Immunocytochemical techniques using specific antisera to pituitary hormones have enabled the identification of five distinct cell types in the anterior lobe48,49 (Table 4). Studies comparing conventional dye techniques with immunocytochemical localisation of pituitary hormones show that the conventional methods do not reliably differentiate the various cell types present47,48,50,51. Some anterior pituitary cells contain more than one hormone and chromophobes, previously thought to be resting acidophils or basophils, or transitory cells, may contain hormones. In addition, cells containing the same hormone can stain variably with dye techniques38. Such discrepancies can be attributed to the staining of substances other than hormones51 or may reflect different stages in cell maturation or the cell secretory cycle47.

Ultrastructural features of the different cell types and their granules11,43 are not sufficiently distinct to allow definitive cell identification1 but are of value when used in conjunction with immunocytochemistry11. It should be noted that there is significant inter-species variation in the structure of the pituitary gland and information from animal studies cannot be extrapolated to humans48.

PATHOLOGY
Variations in the number, size and distribution of the different cell types in the anterior pituitary are seen in a number of conditions. During pregnancy and lactation the gland may increase in size by up to one third due to a true hyperplasia of prolactin secreting cells. Changes in other cell types occur in some endocrinopathies, following surgical removal of pituitary hormone target organs, and in conjunction with certain drug therapies. The gland also shows age related changes43,48. The most significant lesions seen in the pituitary gland are benign adenomas37,38. Current classifications identify ten types of pituitary adenoma based on immunocytochemical demonstration of specific hormone production and tumour cell ultrastructure48,49. Tumour cells may be non-secretory or produce one or more hormones: chromophobic adenomas (the most common type) are able to produce any of the anterior pituitary hormones; acidophilic adenomas produce PRL and/or GH; and basophilic adenomas produce ACTH, b -LPH and/or endorphins48. TSH, LH or FSH secreting adenomas are uncommon37.

Orange G - Acid Fuchsin - Light Green40
SPECIMEN PREPARATION
Cut 3 to 5 µm thick paraffin sections from tissue fixed in mercury-containing fixatives or 10% neutral buffered formalin. A known positive control (pituitary) should be included.

REAGENT PREPARATION
1 Orange G solution
G (CI 16230) 0.5 g
Absolute ethanol 95 ml
Distilled water 5 ml
Phosphotungstic acid 2 g

2 Acid fuchsin solution
Acid Fuchsin (CI 42685) 0.5 g
Distilled water 99.5 ml
Glacial acetic acid 0.5 ml

3 1% phosphotungstic acid
Phosphotungstic acid 1 g
Distilled water 100 ml

4 Light green solution
Light Green (CI 42095) 1.5 g
Distilled water 98 ml
Glacial acetic acid 2 ml

5 Celestine blue/alum haematoxylin

METHOD
1 Dewax and rehydrate sections.
2 Remove mercury pigment with iodine/thiosulphate.
3 Stain nuclei with celestine blue/alum haematoxylin.
4 Rinse in 95% ethanol.
5 Stain sections with orange G solution for 2 minutes.
6 Rinse in distilled water.
7 Stain sections with acid fuchsin solution for 2-5 minutes. Staining is progressive and should be continued until the basophils, but not the background, are strongly stained.
8 Rinse in water.
9 Treat sections with 1% phosphotungstic acid for 5 minutes.
10 Rinse in water.
11 Stain sections with light green solution for 1-2 minutes.
12 Rinse in water.
13 Dehydrate, clear and mount.

RESULTS
Nuclei - blue/black
Acidophils - orange/yellow
Basophils - magenta red
Chromophobes - pale grey/green
Erythrocytes - ;yellow
Stroma - green

TECHNICAL NOTES
1 If tissue has been fixed in formalin, staining can be enhanced by mordanting sections in picro-mercuric-alcohol (a saturated solution of picric acid in absolute alcohol containing 3% mercuric chloride) overnight. This solution is particularly toxic and care is required when preparing or handling it. Subsequently, mercury pigment must be removed with iodine/thiosulphate and the sections washed well in water to remove picric acid staining. Helly's or Bouin's fluids can also be used.
2 Iodine/thiosulphate treatment is recommended, even when mercury-containing solutions have not been used, to enhance staining.

Posterior pituitary
The posterior lobe (or neurohypophysis) is the neural portion containing pituicytes (specialised supportive cells similar to the neuroglial cells of the central nervous system) and unmyelinated nerve axons that originate from neurosecretory cells located in the hypothalamus. The posterior lobe stores and secretes two hormones, oxytocin and vasopressin (anti-diuretic hormone). These are produced by the neuronal cell bodies in the hypothalamus, transported to the posterior lobe along the axons by carrier proteins (neurophysins) and stored as neurosecretory granules (Herring bodies) at the nerve terminals1.

The nerve axons can be demonstrated using silver impregnation techniques. Neurosecretory substances stain blue to purple with Alcian Blue or Aldehyde Thionin in the following anterior pituitary staining methods: permanganate-aldehyde thionin-periodic acid-Schiff-orange G (PM-AT-PAS-OG)46, bromine-alcian blue-orange G-acid fuchsin-light green (Br-AB-OFG)8 or; Bargmann's modification of Gomori's chrome haematoxylin45. Immunocytochemical techniques using specific antisera can demonstrate the hormones secreted (oxytocin, vasopressin), the neural origin of the tissue (S100 protein, neurone specific enolase) and the glial nature of pituicytes (glial fibrillary acidic protein).

Disorders of the posterior pituitary are very rare and usually result in vasopressin deficiency or inappropriate release of vasopressin37.

Between the two main lobes lies the intermediate lobe (a poorly defined region in humans) that contains cystic structures lined by epithelium and filled with colloidal material (remnants of the embryonal Rathke's pouch)1. In other species (amphibians) the cells of the intermediate lobe secrete MSH but in humans the function of these cells is uncertain52.

Paneth cells
STRUCTURE AND FUNCTION
Paneth cells are part of the epithelial lining of the human small intestine but are present only in the base of the crypts of Lieberkühn. Although the precise function of Paneth cells is unclear, lysozyme has been described in the secretory granules, Golgi apparatus and rER53, and immunoglobulins (IgA and IgG) have been demonstrated in the cell cytoplasm54. The presence of lysozyme (an enzyme with limited bactericidal activity that is enhanced in the presence of immunoglobulins and complement) combined with the phagocytic capability of Paneth cells, suggests they are involved in regulation of the microbial flora of the small intestine1. Cationic trypsin immunoreactivity has been demonstrated in human Paneth cells, indicating a possible role in secretion of digestive enzymes55, and their content of heavy metals, particularly zinc, suggests a role in the elimination of metals56.

PATHOLOGY
The response of Paneth cells in pathological conditions is variable. Cell numbers may be decreased due to non-specific injury in inflammatory conditions and increased in regions undergoing regeneration and repair. Reports of alterations in coeliac disease are inconsistent56. Characteristic inclusion bodies are seen (by electron microscopy) in Paneth cells in acrodermatitis enteropathica, a rare autosomal recessive disease characterised by primary zinc deficiency. Following dietary zinc supplementation these inclusions disappear57. Similar inclusions have been reported in neoplastic Paneth cells58.

Metaplastic Paneth cells have been demonstrated in other parts of the gastrointestinal tract in Barrett's oesophagus, chronic gastritis, various inflammatory conditions of the large intestine and in association with some tumours. The presence of metaplastic Paneth cells is thought to represent a non-specific response to the disease state (their evolution and function in these sites is unknown)59.

SPECIMEN PREPARATION
Tissue fixation must be prompt as Paneth cells degranulate rapidly during autolysis. The granules dissolve in fixatives containing acetic acid but are well preserved in 10% neutral buffered formalin or mercuric chloride-formalin (formol sublimate)56,60.

STAINING
Paneth cells are recognised in haematoxylin and eosin stained sections by their large, intensely eosinophilic apical secretory granules and their localisation in the base of the crypts of Lieberkühn. They can also be demonstrated using Lendrum's phloxine tartrazine60, Masson's trichrome (granules stain red with both methods)61 and Mallory's phosphotungstic acid haematoxylin (granules stain blue/black)59,62. The granules stain variably (weakly) with the PAS technique61,62 and react histochemically for tryptophan, tyrosine and sulphydryl and disulphide groups63.

Lendrum's phloxine tartrazine60 is a simple and reliable technique. Nuclei are stained with haematoxylin, followed by cytoplasmic staining with phloxine and subsequent differentiation in a solution of tartrazine in cellosolve. As differentiation continues the red phloxine staining is progressively removed from tissue components that then stain with the yellow tartrazine dye. Paneth cell granules have a strong affinity for phloxine and therefore retain their red colour even after lengthy differentiation. Dye techniques are adequate for demonstrating Paneth cells in sections but immunocytochemical techniques are required to identify specific substances contained within Paneth cells (lysozyme, immunoglobulins, cationic trypsin)53,54,55.

Lendrum's phloxine tartrazine (Lendrum 1947)60
SPECIMEN PREPARATION
Cut 3 to 5 µm thick paraffin sections from tissue fixed in 10% neutral buffered formalin or mercuric chloride-formalin. Avoid fixatives containing acetic acid. Small intestine should be used as control tissue.

REAGENT PREPARATION
1 Phloxine solution
Phloxine B (CI 45410) 0.5 g
Calcium chloride 0.5 g
Distilled water 100 ml

2 Tartrazine in cellosolve64
Tartrazine (CI 19140) 2.5 g
Cellosolve (ethylene glycol monoethyl ester) 100 ml
This is a saturated solution.

3 Celestine blue/alum haematoxylin

METHOD
1 Dewax and rehydrate sections.
2 Stain nuclei with celestine blue/alum haematoxylin.
3 Stain in phloxine solution for 30 minutes.
4 Rinse briefly in water.
5 Differentiate with tartrazine in cellosolve until only the granules stain intensely red (control microscopically).
6 Rinse briefly in water (see note 3).
7 Rinse in 95% ethanol.
8 Dehydrate, clear and mount.

RESULTS
Nuclei - blue
Paneth cell granules - red
Background - yellow

TECHNICAL NOTES
1 Although Lendrum considered the use of an iron haematoxylin unnecessary, it does provide more intense nuclear staining.
2 Calcium chloride added to the phloxine solution intensifies the stain and prolongs the shelf life for up to one year.
3 Lendrum recommended prolonged differentiation followed by thorough washing in water to remove virtually all the yellow tartrazine staining. This facilitates the demonstration of Paneth cells by increasing the contrast. If intense yellow staining is preferred only brief washing is required at step 6.
4 Other tissue components can be demonstrated with this technique by varying the extent of differentiation. These include muscle, fibrin, keratin, viral inclusion bodies, pancreatic B-cell granules and Russell bodies. Appropriate control sections must be used to monitor differentiation.

Seromucous gland cells
seromucous acini are foundin the submandibular and sublingual salivary glands and in subepithelial connective tissue of parts of the upper respiratory tract. In tissue sections, seromucous glands appear s mucous acini with a crescentic cap (demilune) of serous cells. The mucous cells appear pale in H&E stained sections, as the cytoplasmic mucin does not stain or reacts weakly with haematoxylin. both acidic and neutral mucins can be demonstrated in these cells by the alcian blue (pH 2.5) - periodic acid - Schiff (AB-PAS) technique. The apical secretory granules of the serous cells are basophilic, and PAS and PAS-diastase positive.65 They are dissolved in fixatives containing acetic acid, but are well preserved in 10% neutral buffered formalin.66

Mast cells
STRUCTURE AND FUNCTION
Mast cells are normally present in small numbers in the connective tissue of all organs, but particularly in the dermal layer of skin (around blood vessels and nerves), and are identified by their cytoplasmic granules. Mast cells have been considered the tissue equivalent of the circulating basophil but, while there is evidence that they arise from common precursor cell in the bone marrow, there is no evidence that mature basophils are able to differentiate into mast cells67. The two cell types are readily distinguished by their morphology on light microscopy67,68 and the presence of chloroacetate esterase activity in mast cells69.

Mast cells play an important role in immunity, with specific involvement in type I (anaphylactic) hypersensitivity reactions. When IgE antibodies are raised against a particular allergen they can bind to mast cell surface Fc receptors. Subsequent exposure to the allergen triggers mast cell degranulation and the release of chemical mediators, such as histamine and heparin, into the surrounding tissues5. Mast cells are also involved in delayed hypersensitivity, cytotoxicity, immunoregulation and inflammation70.

The content of mast cell granules varies between species and in some pathological conditions. Human mast cells contain histamine, heparin and various proteins, and although serotonin is not normally present, it has been demonstrated in mast cells in the stroma of carcinoid tumours and in mastocytosis68.

A subpopulation of mast cells has been identified at mucosal surfaces, such as in the gastrointestinal and respiratory tracts, in rats and humans. These mucosal mast cells show some structural and functional differences from connective tissue mast cells68,71 and require special fixation conditions or modified staining protocols for their demonstration70,72-75.

PATHOLOGY
Increased numbers of mast cells are found in many pathological conditions. Mast cell hyperplasia in the skin (mastocytosis) manifests with skin lesions and may present with symptoms of urticaria and flushing due to the chemical mediators released during mast cell degranulation. Children may develop single mastocytomas or the multiple cutaneous lesions of urticaria pigmentosa. In adults, multiple organ involvement can occur (notably affecting bone, liver, spleen and lymph nodes) even without apparent skin lesions (systemic mastocytosis). Lesions of the bone may be localised or widespread, osteoclastic or osteoblastic76. Increased mast cell numbers are also seen in some inflammatory bowel diseases (ulcerative colitis, Crohn's disease) and in parasitic infections68. Cutaneous neurofibromas, benign and malignant breast lesions, and some soft tissue tumours also show high numbers of mast cells.

SPECIMEN PREPARATION
Fixation must be rapid to avoid cytoplasmic degranulation and deterioration of granule contents. Neutral buffered formalin (10%) preserves morphology and enables demonstration of connective tissue mast cell granules using a variety of staining techniques. Special fixation is required for the demonstration of mucosal mast cells as aldehydes reversibly block cationic dye-binding sites74. Carnoy's fluid (minimum fixation time: two hours) or isotonic-formol-acetic acid (1.5% formalin, 0.5% glacial acetic acid - minimum fixation time: two days) are suitable73. Alternatively, mucosal mast cells can be demonstrated in aldehyde fixed tissue by increasing the staining time74.

STAINING
Mast cells are not readily identified in haematoxylin and eosin stained sections (the granules are refractile and do not stain) but are well demonstrated by a number of special staining methods. The most common are metachromatic dye techniques and the demonstration of chloroacetate esterase activity.

METACHROMATIC DYE TECHNIQUES
Metachromatic dyes, such as Toluidine Blue and Azure A, demonstrate the strongly sulphated acid mucopolysaccharide (heparin) content of mast cell granules. The acidified toluidine blue method of Churukian and Schenk77 is simple, rapid and reliable. Sections are oxidised with permanganate, decolourised and then stained in an acidified solution of Toluidine Blue. The low pH (3.2) of the solution minimises background and enhances nuclear staining (both nuclear and background staining can be eliminated by lowering the pH to 0.568).

Acidified toluidine blue77
SPECIMEN PREPARATION
Cut 3 to 5 µm thick paraffin sections from tissue fixed in 10% neutral buffered formalin. Tissue known to contain mast cells (neurofibroma, skin) is used as a control.

REAGENT PREPARATION
1 0.5% aqueous potassium permanganate
Potassium permanganate 0.5 g
Distilled water 100 ml

2 2% aqueous potassium metabisulphite
Potassium metabisulphite 2 g
Distilled water 100 ml

3 Acidified toluidine blue solution (pH 3.2)
Distilled water 99.75 ml
Glacial acetic acid 0.25 ml
Toluidine Blue (CI 52040) 0.02 g

METHOD
1 Dewax and rehydrate sections.
2 Transfer sections to potassium permanganate solution for 2 minutes.
3 Rinse in distilled water.
4 Transfer sections to potassium metabisulphite solution for 1 minute (or until sections appear white).
5 Wash in tap water for 3 minutes.
6 Rinse in distilled water.
7 Place in acidified toluidine blue solution for 5 minutes.
8 Rinse in distilled water.
9 Dehydrate rapidly, clear and mount.

RESULTS
Mast cell granules and other strongly sulphated acid mucopolysaccharides - purple
Nuclei - blue

TECHNICAL NOTE
Mast cells and eosinophils can be demonstrated in the same section by staining with Congo Red before acidified toluidine blue78 and this technique can be modified for undecalcified bone sections79.

A prolonged staining protocol74 can be used to demonstrate mucosal mast cells in aldehyde fixed tissue, connective tissue mast cells after prolonged aldehyde fixation or the presence of low numbers of mast cells in highly cellular tissue (such as lymph node). Sections are treated with a 0.5% solution of Toluidine Blue in 0.5 mol/l HCl (pH 0.5) for 5-7 days, filtering the solution on alternate days. The mucosal mast cell granules stain dark blue against a clean background. An eosin counterstain (1% eosin in 70% ethanol for 20 seconds) will improve contrast and allow tissue orientation. Eosinophils are demonstrated after counterstaining with eosin at pH 10.

CHLOROACETATE ESTERASE ACTIVITY
Mast cell granules contain proteases, including esterases that rapidly hydrolyse the a -chloroacyl esters of a -naphthol and naphthol AS80. Chloroacetate esterase activity is demonstrated by a simultaneous capture technique using the substrate naphthol AS-D chloroacetate and diazonium salts such as pararosaniline, Fast Blue RR or Fast Garnet GBC81,82,83. Mast cell granules are demonstrated after a short incubation time, before other tissue staining becomes apparent. Leucocytes of the myeloid series are also demonstrated. Pararosaniline is preferred as it forms an insoluble red/pink reaction product and sections can be mounted in synthetic resin. Fast Blue RR forms a vivid blue reaction product and Fast Garnet GBC a red product, but both are soluble in organic solvents and require an aqueous mountant.

Chloroacetate esterase82,84
SPECIMEN PREPARATION
Cut 3 to 5 µm thick paraffin sections from tissue fixed in 10% neutral buffered formalin. Do not use acid-containing fixatives such as Zenker's or Bouin's. Fix smears/imprints for 30 minutes in a solution of 9 parts methanol, 1 part formalin. Wash in tap water and air dry. Tissue known to contain mast cells (or kidney - tubule lining cells; liver - hepatocytes, Kupffer cells) is used as a control.

REAGENT PREPARATION
1 4% pararosaniline in 2 mol/l HCl
Pararosaniline (CI 42500) 0.4 g
Distilled water 8.4 g
Concentrated hydrochloric acid 1.6 ml
Dissolve the pararosaniline in the water. Add the acid slowly.

2 4% aqueous sodium nitrite
Sodium nitrite 0.4 g
Distilled water 10 ml

3 0.07 mol/l phosphate buffer pH 6.5
a) Disodium hydrogen orthophosphate (anhydrous) 9.465 g/l
b) Sodium dihydrogen orthophosphate 10.452 g/l
Mix 30 ml of solution a) and 70 ml of solution b).

4 Substrate solution
Naphthol AS-D chloroacetate 0.01 g
(Store below 0°C)
N-dimethylformamide 1 ml

5 Mayer's haematoxylin

METHOD
1 Dewax and rehydrate sections.
2 Mix 0.1 ml pararosaniline (solution 1), with 0.1 ml of sodium nitrite (solution 2). Leave for 30-60 seconds.
3 Add 30 ml of buffer (solution 3). Check that the solution is at pH 6.3.
4 Add substrate (solution 4), mix and filter.
5 Immediately place sections in the solution and incubate at room temperature for 30 minutes.
6 Check microscopically; if the reaction is incomplete, refilter the solution and reincubate sections for further 15-30 minutes.
7 Wash slides in water for 5 minutes.
8 Counterstain in Mayer's haematoxylin for 5 minutes.
9 Wash in water.
10 Dehydrate, clear and mount.

RESULTS
Esterase activity - red/pink
Nuclei - blue

TECHNICAL NOTES
1 Sections should not be treated with iodine/thiosulphate to remove mercuric pigment as this may reduce the intensity of staining.
2 Do not overheat sections when drying as this destroys enzyme activity.
3 Solutions 1 and 2 keep for at least a month but the reaction solution must be made up fresh each time.
4 If the solution turns red when the buffer is added (step 3) the reaction of pararosaniline with the nitrite was incomplete and a fresh solution should be prepared.

A combination of Human Platelet Factor 4 (HPF 4) which binds to heparin and an anti-HPF 4 antibody can be used to specifically demonstrate mast cell granules in formalin-fixed, paraffin-embedded tissue sections by immunocytochemical techniques85. An antiserum directed against histamine has also been used in an indirect immunofluorescent technique on frozen sections. Positive immunostaining in mast cells was only produced in tissue fixed in 4% carbodiimide in O.1 mol/l phosphate buffer (pH 7.4)86. Lectins (000) have been used in studies on the heterogeneity of mast cells87.

Romanowsky techniques
HISTORY
88-92
In 1879 Ehrlich described the use of 'neutral' dyes (mixtures of acidic and basic dyes) for the differentiation of cells in peripheral blood smears. In 1891 Romanowsky and Malakowsky independently developed a method which used mixtures of Eosin Y and 'ripened' Methylene Blue that not only differentiated blood cells, but also demonstrated the nuclei of malarial parasites. A number of 'ripening' (oxidation or polychroming) techniques were investigated by different groups (Unna 1891, Nocht 1898) but the aqueous dye solutions produced were unstable and precipitated rapidly. Subsequently, methanol was introduced as a solvent for the dye precipitate (Jenner 1899, England; May and Grünwald 1902, Germany) and techniques were developed that utilised the fixative properties of the methanolic solution, prior to aqueous dilution for staining (Leishman 1901, England; Wright 1902, Germany). Giemsa (1902) further improved these techniques by using more controlled methods of oxidation with measured amounts of known dyes, and adding glycerol to the methanol solvent to increase the solubility and stability of the dyes.

TRADITIONAL FORMULAE AND MECHANISM OF STAINING
Traditional Romanowsky-type dyes are produced by oxidation (polychroming) of Methylene Blue in aqueous solution, using heat and alkali. The resulting solution contains a mixture of Azure A, Azure B, Methylene Violet and Methylene Blue. A measured quantity of Eosin Y is then added to produce a 'neutral' dye. The precipitate formed is dissolved in methanol, or a mixture of equal volumes of methanol and glycerol, to produce a stable stock solution. Working solutions are prepared by diluting the stock solution with distilled water, or an aqueous buffer, to allow ionisation of the dyes. Typical staining results obtained using air-dried, methanol-fixed smears are:

nuclear chromatin                     purple
nucleoli                                    blue
'basophilic' cytoplasm               blue
basophil granules                      purple/black
neutrophil granules                   purple
platelet granules                        purple
eosinophil granules                  pink/orange
erythrocytes                               pink
nuclei of parasitic protozoa      red to red/purple

The full range of colours obtained cannot be accounted for by ionic binding alone88. The 'red' staining of the nuclei of parasitic protozoa is thought to be produced by the azure dye and eosin binding to the basic protein protamine, rather than the nuclear chromatin, to produce an imino base of the azure dye (which is red). Metachromasia also contributes to the staining pattern observed. Mixtures of pure azure B and eosin Y alone can also produce the same staining pattern as traditional Romanowsky-type dye mixtures93.

CURRENT PRACTICE
Romanowsky-type stains are used routinely in haematology and cytology but are not commonly applied to tissue sections. The examination of smears or imprints and thin (1-2 µm) sections stained with both H&E and a Romanowsky-type stain is recommended for optimal evaluation of bone marrow94,95 and lymphoid tissues89,96. Advantages of Romanowsky-type staining over haematoxylin and eosin include: demonstration of mast cell granules; differentiation of mucosubstances; and identification of blood and marrow cells of different lineages and stages of maturation97,98. Numerous modifications of the Romanowsky method have been described, particularly for application to tissue sections and, although the various techniques may produce slight differences in staining, the basic mechanisms and staining effects are the same. The staining obtained in tissue sections is more variable than in smears because the protocols used require additional steps (differentiation, dehydration, clearing) and tissue sections contain more stainable components98. Some stains are used in combination to produce the desired colouring of cell and tissue component as for example with the Jenner-Giemsa and May Grünwald-Giemsa techniques99.

SPECIMEN PREPARATION
Bone marrow cores require fixation and decalcification before processing. Zenker's fluid, which simultaneously fixes and decalcifies tissue, is recommended, but formalin fixation followed by mild acid or EDTA decalcification can be used. However, formalin fixation alters the expected staining pattern with the nuclei staining dark blue and the cytoplasm pale blue100, although the staining of cytoplasmic granules remains unchanged. Decalcification causes some loss of cellular detail95 and can also affect the staining pattern98,101. It may also be difficult to obtain good quality, thin (1-2 µm) sections of paraffin-embedded tissue. Alternatively, undecalcified tissue can be embedded in resin and thin (2 µm) sections prepared, to provide improved cellular morphology. One disadvantage of resin sections is the extended staining times required, but these can be significantly reduced when microwave-assisted techniques are used97. These also produce more intense staining with improved contrast, however, the characteristic staining pattern is altered, with RNA-rich sites such as nucleoli and 'basophilic' cytoplasm staining purple rather than blue97,102. A 24 hour protocol for processing and staining (H&E, Giemsa, reticulin) resin sections without microwaves has been described103.

Lymphoid tissue can be processed routinely to paraffin wax or resin and thin (1-2 µm) sections prepared. Smears and imprints should be air-dried and fixed in methanol for 1 to 5 minutes before staining, depending upon the technique.

Factors affecting staining89,91,100,104
THE STAIN
Stock stains
Stains are available commercially as dry powders or stock solutions. For storage, powders are most stable, and stock solutions in a methanol/glycerol solvent mixture are more stable than those in methanol alone. Different brands and batches can produce variable staining and therefore reagents should be carefully selected and the stain quality continually monitored105. Stock stains should be stored in tightly capped polyethylene containers, in the dark at 4°C to prolong shelf life, as they are affected by moisture, contact with metals, exposure to light and variation in temperature.

Working solutions
Working stain solutions are prepared by diluting the stock with distilled water or an aqueous buffer. The buffer composition, and the concentration and pH of the working solution (6.0 to 8.5) all affect staining. The colour of erythrocytes, in particular, is altered by changes in the pH (pH 6.0 - red, pH 7.5 - colourless, pH 8.5 - bluish green)92. Working solutions are stable for only a few hours and should be freshly prepared in small volumes. Deterioration of dye solutions is evidenced by loss of red staining due to eosin precipitation100.

THE STAINING PROTOCOL
The staining time must be long enough to achieve differential staining97,106, but if excessive, then effective differentiation may not be possible98. The best differential staining is achieved using a more dilute staining solution with a longer incubation time101. Differentiation is usually performed in two steps: 1) dilute acetic acid to remove excess blue staining and; 2) 95% ethanol to remove excess Eosin. These steps are difficult to standardise and sections must be processed individually under microscopical control.

Jenner Giemsa28 for bone marrow sections
SPECIMEN PREPARATION
Cut 2 µm thick paraffin sections from tissue fixed in Zenker's fluid or 10% neutral buffered formalin. Bone marrow or tonsil are used as control tissue.

REAGENT PREPARATION
1 Jenner stock solution:
Jenner stain powder 1 g
Methanol 400 ml
(A commercial stock solution can be used).
Jenner working solution:
Jenner stock solution 25 ml
Distilled water 25 ml

2 Giemsa stock solution: Giemsa powder 1 g
Glycerol 66 ml
Methanol 66 ml
Mix the powder with the glycerol and place at 60°C for 2 hours. Add the methanol and mix well. (A commercial stock solution can be used).
Giemsa working solution:
Giemsa stock solution 2.5 ml
Distilled water 50 ml

3 1% acetic acid
Glacial acetic acid 0.5 ml
Distilled water 50 ml

METHOD
1 Dewax and rehydrate sections.
2 Remove mercuric pigment with iodine/thiosulphate if necessary.
3 Rinse in distilled water.
4 Rinse in two changes of methanol.
5 Place sections in working Jenner solution for 6 minutes.
6 Transfer to working Giemsa solution for 45 minutes.
7 Rinse rapidly in distilled water.
8 Differentiate in 1% acetic acid (control microscopically).
9 Rinse rapidly in distilled water.
10 Dehydrate rapidly, clear and mount.

TECHNICAL NOTE
May and Grünwald's solution can be used in place of Jenner's but requires a longer staining time (45 minutes).

Lennert's Giemsa96 for lymph nodes
SPECIMEN PREPARATION
Cut 2 µm thick paraffin sections from tissue fixed in Zenker's fluid or 10% neutral buffered formalin. Lymph node or tonsil are used as control tissue.

REAGENT PREPARATION
1 Working Giemsa solution
Giemsa stock (Merck) 10 ml
Distilled water 40 ml

2 Acetic acid solution
Add 1-2 drops of glacial acetic acid to 50 ml distilled water.

METHOD
1 Dewax and rehydrate sections.
2 Remove mercuric pigment with iodine/thiosulphate if necessary.
3 Place sections in working Giemsa solution for 1 hour.
4 Rinse briefly in acetic acid solution.
5 Place in 96% ethanol until differentiated (control microscopically.
6 Rinse in two changes of isopropanol each of 2 minutes.
7 Clear and mount.

RESULTS (for both methods)
Nuclear chromatin - dark blue
Cytoplasm of lymphocytes and monocytes - pale blue
Neutrophil granules - purple
Eosinophil granules - pink/orange
Basophil granules - purple/black
Nucleoli - blue
Erythrocytes - pink
Connective tissue - pink to light purple
Mast cell granules - dark purple

Organelles
Suspended within the cytoplasm of eucaryotic cells are various structures107 which are either: (a) membranous or membrane bound, perform specialised functions and form distinct subcompartments in their own right; or (b) are not membrane bound and, although they have specialised functions, do not form subcompartments within the cytoplasm. A variety of structures may be defined as organelles but here only those in group (a) are included. These are mitochondria, the endoplasmic reticulum, endosomes, peroxisomes, lysosomes, and the Golgi apparatus and its associated vesicles.

Organelles and other subcellular structures can only be visualised in a limited manner by conventional light microscopy. The smallest objects that can be seen are approximately 250 nm (0.25 µm) in diameter and, as most organelles are smaller than this, electron microscopy with its superior resolving power is more useful than light microscopical techniques which are restricted to mitochondria, the Golgi apparatus and lysosomes. However, histochemical and immunocytochemical techniques may also be used, with either light or electron microscopy.

Mitachondria
Mitochondria are approximately 0.5-1 µm in diameter and 2-5 µm in length and appear as threads or grains by light microscopy. All eucaryotic cells contain mitochondria that possess their own genome and are self replicating. Mitochondria contain a concentrated mixture of enzymes and are the major site of oxidative phosphorylation, supplying the cell's energy requirements by producing adenosine triphosphate (ATP).

PATHOLOGY
In normal cells mitochondria increase in number with increasing metabolic load and are also found in large numbers in oncocytomas. In the early stages of cellular injury both the mitochondria and endoplasmic reticulum may become swollen through an influx of water into the cell leading to cloudy swelling or hydropic change.108 Structural alterations to mitochondria, such as pleomorphism, gigantism, ultrastructural abnormalities and inclusions, as well as quantitative changes, are found in a variety of neoplastic and non-neoplastic diseases11,109 however, most of these changes cannot be demonstrated by light microscopy. In addition, enzyme alterations which occur in some disease states, are not always accompanied by morphological change109 but can be demonstrated histochemically.110

VITAL STAINS
In living tissue mitochondria can be visualised in unstained preparations by dark ground illumination or phase contrast microscopy. Alternatively, they can be demonstrated using supravital stains including: Janus Green B; Janus Blue; Janus Black; diethylsafranin; Pinacyanol; Rhodamine B; Methylene Blue;66 and the fluorescent, cationic, lipophilic dye Rhodamine 123.111 Mitochondria are sensitive to osmotic change and, in unfixed tissue, must be observed promptly and prior to autolysis.

JANUS GREEN B
Isolated cells are suspended in an isotonic solution containing Janus Green B (CI 11050) at a concentration of 1:10,000 (or weaker). Small portions of fresh tissue may be gently crushed in the same solution. Mitochondria stain a deep blue-green in approximately 5-10 minutes but the colouration is temporary. The methods for most other supravital stains are similar.

Pinacyanol-neutral red112-113
Pinacyanol is claimed to be superior to Janus Green as it is less toxic and gives longer lasting preparations.

SPECIMEN PREPARATION
The technique may be used with blood (fresh, no anticoagulant), bone marrow, thin tissue slices, or crushed tissue fragments.

REAGENTS REQUIRED
1 0.4% aqueous Neutral Red (CI 50040) (a saturated solution)
2 0.1% Pinacyanol (CI (Ed.1) 808) in absolute alcohol
Mix 0.58 ml of the neutral red solution with 0.17 ml of pinacyanol. Make up to 5 ml with absolute alcohol. As an alternative, Lillie and Fullmer66 recommend mixing 0.3 ml of pinacyanol with 1 ml of neutral red and then adding 8.7 ml of absolute alcohol to give a final volume of 10 ml.

METHOD
1 Coat clean slides with the stain mixture, drain and air dry.
2 Apply the specimen to a clean coverslip. The material is wetted with serum, or an alternative isotonic solution, and spread in a thin layer (preferably one cell thick) without air bubbles.
3 Place the coverslip onto a prepared stain-coated slide, sandwiching the specimen between the coated surface and the coverslip. Edges may be sealed with a suitable sealant (petroleum jelly).
4 Incubate for approximately 20 minutes at 37°C, or slightly longer at room temperature (monitor microscopically). Preparations made at room temperature last longer than those made at 37°C. It is recommended that observations are completed within 90 minutes, however, staining may remain for 2-4 days.

RESULT
Mitochondria - deep blue to violet, or purple in living cells
Nuclei - red

TECHNICAL NOTE
Pinacyanol is photosensitive, therefore both the coated slides and stock solution must be stored in the dark.112 Coated slides last approximately two weeks and the stock solutions for up to 6 months.

Rhodamine 123111
Rhodamine 123 is a specific vital fluorescent dye that stains mitochondria without first having to pass through endocytotic vesicles or lysosomes. High resolution staining is achieved with low background.111 The dye has low cytotoxicity but dimethyl sulphoxide, recommended by some as an alternative solvent, is mildly cytotoxic and aqueous solutions are preferred.114

REAGENTS REQUIRED
1 Rhodamine 123
2 Dulbecco's modified Eagle's tissue culture medium
3 Double distilled water
Dissolve the rhodamine 123 in double distilled water at a concentration of 1 mg/ml, then dilute to 10 µg/ml in Dulbecco's modified Eagle's tissue culture medium.

METHOD
1 Incubate cultured cells (on coverslips) in the stain solution for 30 minutes in a 10% CO2 incubator at 37oC.
2 Wash the cells in three changes of fresh medium without rhodamine each of 5 minutes.
3 Mount in fresh medium supplemented with 10% fetal calf serum.
4 Examine with a live cell observation chamber. Stained cells are viewed using epifluorescent illumination at either 546 nm (rhodamine excitation) or 485 nm (fluorescein excitation), or using confocal microscopy.

RESULTS
At 485 nm, mitochondria - green fluorescence, similar in colour to fluorescein excitation
At 546 nm, mitochondria - red fluorescence

FIXED TISSUE
A number of protocols based on the method of Altmann (1894)115 have been described for the demonstration of mitochondria in fixed tissue.8,66 In this method the tissue is fixed in chrome-osmium, stained with a hot strong acid fuchsin solution and differentiated with picric acid.115 The methods described here are limited to those that are simple and easy to perform. As mitochondria are osmotically sensitive and quick to show post mortem change, small pieces of tissue should be fixed rapidly. To maximise resolution, material is embedded in ester wax and sections are cut at 2 µm, however, paraffin sections may also be used.

Phosphotungstic acid haematoxylin (PTAH)8
SPECIMEN PREPARATION
See Chapter 5.2
REAGENTS REQUIRED
1 PTAH (See Chapter 5.2)
2 4% aqueous iron alum

METHOD
1 Dewax and rehydrate sections.
2 Mordant in 4% iron alum for 20 to 60 minutes.
3 Wash well in distilled water.
4 Stain for 1-16 hours in PTAH as required. Alternatively sections can be stained in PTAH for 1-2 hours at 60°C.
5 Rinse very briefly in 95% alcohol.
6 Dehydrate, clear, and mount.

RESULTS
Nuclei and mitochondria - blue

Chromotrope-aniline blue (CAB)116
This stain is used for the demonstration of giant mitochondria, particularly in liver.
SPECIMEN PREPARATION
Cut 2 µm thick paraffin or 5 µm thick frozen sections from tissue fixed in 10% neutral buffered formalin. Fresh tissue can also be used for frozen sections.

REAGENTS REQUIRED
1 Chromotrope-aniline blue solution (CAB):
Hydrochloric acid (concentrated) 2.5 ml
Distilled water 200 ml
Aniline blue (CI 42780) 1.5 g
Chromotrope 2R (CI 16570) 6 g
Add the hydrochloric acid to distilled water then dissolve the aniline blue in the resulting solution, using gentle heat. Add chromotrope 2R and mix to dissolve. The final solution should have a pH of 1.0.
2 Weigert's iron haematoxylin
3 1% aqueous phosphomolybdic acid

METHOD
1 Dewax and rehydrate sections.
2 Stain nuclei with Weigert's haematoxylin.
3 Rinse in distilled water.
4 Immerse in 1% phosphomolybdic acid for 1-3 minutes.
5 Rinse in distilled water.
6 Stain with CAB solution for up to 8 minutes (ideally 2-4 minutes).
7 Rinse well in distilled water and blot dry.
8 Dehydrate quickly, clear, and mount.

RESULTS
Giant mitochondria - red or orange-red
Collagen - blue
Nuclei - black
TECHNICAL NOTE
In liver sections care should be taken not to confuse giant mitochondria with Mallory bodies that normally stain blue but may occasionally be red.

The Golgi apparatus
The Golgi apparatus was first described in animal neurones in 1898.117-118 It is usually located near the nucleus and consists of a stack of flattened membrane bound cisternae that vary in number (usually from 3 to 12) and are approximately 1 µm in diameter.107,109 Immediately adjacent are numerous small vesicles (~50 nm in diameter) which are thought to transport proteins and lipids from the endoplasmic reticulum to the Golgi and also between the cisternae. The cisternae are organised in a sequential series and material that enters the Golgi is modified and processed in a stepwise manner. Compounds are received into the primary cis compartment (forming face), pass to the medial cisternae (central), and then to the trans cisternae (maturing face). After sorting, material is distributed to the plasma membrane, lysosomes, and secretory vesicles.119 Histochemical techniques are useful for demonstrating Golgi, but only those performed at the ultrastructural level will reveal the contents (and thus the function) of the individual cisternae. In blood smears stained with H&E the Golgi apparatus can be seen in some cells (such as plasma cells) as a pale unstained area. In tissue sections the Golgi are demonstrated by impregnation with silver, osmium tetroxide, or both, however these techniques appear to stain only the cis face.120 Special fixation is a prerequisite for these methods, they are also technically difficult and require experience to achieve good quality, consistent results. A number of methods (with variations) are described by Lillie and Fullmer.66

Lysosomes
Lysosomes are a heterogenous group of membrane bound spherical or ovoid cytoplasmic vesicles ranging in size from 0.025 µm to 0.8 µm. They are defined biochemically by the presence of acid phosphatase but more than 60 lysosomal enzymes have been demonstrated, principally acid hydrolases with a small number of oxidoreductases121. Their main functions are summarised as follows:

During intracellular digestion, cell components are sequestered and fused with a primary lysosome to form a secondary lysosome (an autophagic vesicle). After enzymic breakdown the remaining undigested material is known as a residual body, the brown pigment lipofuscin being a typical example. Secondary lysosomes and residual bodies may also contain a variety of metals, particularly iron, but gold, uranium, silver, copper, thorium, and others, have also been recorded.122

Lysosomes are prominent in a variety of diseases such as melanosis coli and melanosis duodeni as well as some granular cell tumours.122 Lysosomes also play an important role in diseases such as rheumatoid arthritis, in which lysosomal enzymes contribute to the inflammatory process. Abnormal lysosomes are found in the hereditary mucopolysaccharidoses and in drug induced lysosomal storage diseases.109,122

Lysosomes in neutrophils (primary granules) are demonstrated using Romanowsky techniques and iron rich residual bodies, such as those found in hepatic lysosomes in haemochromatosis, are demonstrated using Perls' Prussian blue. Lipofuscin stains strongly with Sudan Black B (less so with Sudan IV) and is generally PAS positive. Antibody labelling techniques and methods for the histochemical demonstration of lysosomal enzymes have been described.123

VITAL STAINS
A variety of dyes have been used for vital staining and fluorescence microscopy of lysosomes124 but Acridine Orange (Euchrysine 3R, 3,6-bis-dimethylaminoacridine) is particularly useful.125

Acridine Orange Staining (for cell monolayers)125
This method can be adapted for the in vitro staining of cell suspensions and subcellular fractions, and to stain lysosomes in vivo.

REAGENTS REQUIRED
Acridine orange (CI 46005)
Hank's balanced salt solution

METHOD
1 Add acridine orange to the cell cultures (on coverslips) in culture medium to give a final concentration of 1 µg/ml.
2 Incubate in the dark for 30 minutes.
3 In subdued light replace the culture medium with fresh medium (without acridine orange) and incubate in the dark for a further 15 minutes.
4 Dry the cell-free side of the coverslip and mount on a slide using Hanks' balanced salt solution, sandwiching the cells between the slide and the coverslip. The coverslip may be sealed with a suitable sealant.
5 Examine for fluorescence with dark ground transmitted light or incident light (using optics suitable for fluorescein isothiocyanate).

RESULT
Lysosomes fluoresce orange

TECHNICAL NOTE If cells stained with Acridine Orange are examined for long periods photosensitisation damage may occur. This causes lysosomes to enlarge and fuse and release dye into the cytoplasm.

Other cytoplasmic inclusions
Other cytoplasmic components of diagnostic significance include the filaments of the cytoskeleton that aggregate to form large inclusions (keratin and it's related end products, and alcoholic hyaline) and some secretory products, particularly Russell bodies. Methods for the demonstration of these structures are described below.

Keratin and keratohyalin
The keratins are cytoplasmic fibrous polypeptides which form the cytoskeleton; they are classed as Type I intermediate filaments (diameter: 10 nm). Their component polypeptides are subdivided into the acidic keratins (40-70 kDa) and the neutral and basic keratins (40-70 kDa). Individual keratin filaments are heteropolymers of these subgroups with 19 types described in human epithelium and an additional 8 types in hair and nails.119 In the epidermis, keratinocytes synthesise a sequence of different keratin filaments as they mature. These gradually compact and become cross-linked, both to one another and to associated proteins, and the cells containing them eventually form a layer of dead keratinised cells on the skin surface. Nail and hair form similarly.

Hair and keratin stain deep pink with H&E and, due to their high sulphur content, can be demonstrated using amino-acid histochemical methods for disulphide and sulphydryl groups (such as the performic acid-alcian blue technique).66 Keratin is also birefringent, takes up picric acid strongly, is weakly Gram positive, stains black with Heidenhain's haematoxylin, stains red with Masson's trichrome, and retains phloxine (red) during differentiation in Lendrum's phloxine tartrazine technique.8,63 As a group, intermediate filaments (Types I-IV) are important diagnostic tumour markers when demonstrated using specific antibodies.126

Keratohyalin is involved in the intracellular compaction and cross-linking of keratin filaments during keratinisation and consists mainly of the protein filaggrin.127 By light microscopy, keratohyalin is seen as irregular basophilic granules, particularly in the stratum granulosum of the epidermis and in the layer of Huxley in hair follicles. Keratohyalin granules are deep blue or purple with H&E, purple with Masson's trichrome and colour intensely with progressive alum haematoxylin and iron haematoxylin, but moderately with basic aniline dyes.66 Keratohyalin is usually Gram positive and periodic acid and peracetic acid Schiff-negative. The keratohyalin in hair follicles (tricohyalin) stains vividly with acid dyes but does not stain with haematoxylin.8,63,66

Mallory bodies
Mallory bodies are rope-like, sausage or irregular antler-shaped cytoplasmic inclusions found in hepatocytes. They were first described by Mallory in alcoholic liver disease128 but have subsequently been seen in a wide variety of liver conditions unrelated to alcohol.129 Inclusions with a similar morphology, such as those described in the lung as Mallory body-like,130 should not be included, the term being restricted to the cytoplasmic inclusions found in pathologically altered hepatocytes.

Mallory bodies consist of clusters of abnormal Type I intermediate filaments with no delimiting membrane,122 sometimes in association with ubiquitin.131 Normal filaments may be present, but Mallory body formation is usually accompanied by derangement and loss of the normal cytoskeleton.132-133 Immunocytochemical studies have shown that, not only do the filaments contain unique epitopes not present in the cytoskeleton of normal hepatocytes, they may also contain inappropriate epitopes, labelling with antibodies against bile duct cytokeratins.134-136 Changes in DNA can also be associated with Mallory body formation (hyperploidy and aneuploidy) but these do not necessarily cause the cytoskeletal alterations.137 Based on their ultrastructural appearance three filament variants have been described:138
Type 1 parallel or whorled formation, mean diameter 14 nm
Type 2 random orientation, mean diameter 15 nm
Type 3 amorphous with loss of fibrillar structure

Using conventional techniques Mallory bodies are PAS negative and eosinophilic, staining pink to red with H&E. They are more specifically demonstrated using Liisberg's rhodamine B, appearing pale blue to pale pink by white light microscopy or bright yellow using fluorescence microscopy. With chromotrope-aniline blue (CAB) Mallory bodies stain blue (Fig 8), but occasionally red, in which case they may be difficult to distinguish from giant mitochondria.139 They can also be demonstrated using keratin stains.140 In the definitive paper by Mallory128 they were visualised using phosphotungstic acid haematoxylin. As small Mallory bodies are invisible using routine staining techniques, immunocytochemical localisation using a Mallory body specific antibody is recommended.141

Fig 8 - Mallory bodies (blue-arrowed) demonstrated in human liver using the chromotrope - aniline blue technique. Formalin-fixed, paraffin-embedded tissue, 4µm thick sections.

Russell bodies
Acidophilic hyaline bodies in neoplastic cells were first noted by Russell142 who suggested they were fungal and part of the neoplastic process, describing them as the "characteristic organism of cancer". The term 'Russell body' is now used mainly for the rounded bodies found in cells derived from B-lymphocytes.143 Although rare in normal plasma cells, Russell bodies may be common in reactive plasma cell populations,144 the plasma cells of autoimmune mutant mice,145-146 plasma cell abnormalities such as multiple myeloma,147 and lymphoproliferative disorders.148 Plasma cells containing large numbers of Russell bodies are known as Mott cells149 (also as thesaurocytes; or morular, grape, or flame cells150). However, when Mott cell inclusions are basophilic rather than acidophilic they are sometimes referred to as Mott bodies.150-151

Typically, the Russell bodies of B-lymphocyte derivatives are located within rough endoplasmic reticulum, have the appearance of inclusion or storage bodies145 and, at the ultrastructural level, are round, oval, crystalline (polyhedral or rod-like), or lobular (medusoid).11,146,151-152 In Mott cells, cytoplasmic inclusions have been observed outside the rough endoplasmic reticulum.151 Intranuclear forms also occur120,153 and are occasionally referred to as Dutcher bodies.154 Extracellular Russell bodies are relatively uncommon. It has been shown by immunocytochemistry that Russell bodies contain a variety of glycoproteins, particularly immunoglobulins145-146,148,155 and Russell body formation in Mott cells is dependent upon the immunoglobulin isotype being IgM.156 These immunoglobulins are thought to accumulate because of faulty synthesis, assembly or secretion.145,155 Alternatively, they may be unused immunoglobulin components manufactured in excess during antibody production,157 or the result of increased immunoglobulin synthesis accompanied by impaired secretion.146

Russell-type acidophilic inclusions up to 30µm in diameter have been observed in a variety of tumour cells besides those of B-cell origin.158-159 These bodies form a heterogenous group and include typical storage or secretory inclusions, enlarged organelles and lysosomal structures. They may contain glycoprotein,158 or mucopolysaccharide-protein complexes (mucoprotein).159 Immunolabelling studies of Russell-type bodies in adenocarcinomas show only weak positivity for immunoglobulins,158 suggesting that these are not a major component of tumour cell inclusions, unlike the Russell bodies of B-cell derivatives.

Russell142 demonstrated up to 20 red or purple-red inclusions per cell using Eosin and logwood (haematoxylin) or carbol fuchsin and iodine green. No specific staining regime is available for Russell bodies which stain pink with H&E (although the acidophilia may be variable160). Staining by Romanowsky mixtures varies depending upon the pH of the stain in relation to the isoelectric point of the constituent protein.161 The majority of Russell bodies are periodic acid-Schiff (PAS) and PAS-diastase (PAS-D) positive but PAS and PAS-D negative forms also occur.148,153,160 Russell bodies also give a positive Millon reaction; are Gram-positive (negative with acetone differentiation); stain variably with Mallory's phosphotungstic acid-haematoxylin; are variably positive with the Ziehl-Neelsen acid fast technique;158-159 stain brick red with Masson's trichrome;158 stain red with phloxine tartrazine; and are usually negative with stains for amyloid, mucopolysaccharides, lipids, myelin, nucleic acids, and non-specific esterases.146,155,158-159

Nucleolar organiser regions (AgNOR's)
The structure and function of AGNOR'S
Ribosomes are composed of ribonucleic acid (RNA) and produced as individual copies from specific genes. Protein synthesis within cells requires large numbers of ribosomes therefore, to boost ribosome manufacture, the genes which code for the large ribosomal RNA's (rRNA) are present as multiple copies. In humans these copies are organised as tandemly arranged sets of identical genes located near the tips of the short arms of the acrocentric (asymmetrical) chromosomes 13, 14, 15, 21 and 22. During interphase the regions containing these genes form deoxyribonucleic acid (DNA) loops which extend into the nucleolus and are the major site of ribosome production.119 Each individual gene cluster forms a nucleolar organiser region (NOR) which comprises a rounded fibrillar centre surrounded by a dense fibrillar component. Genes that are actively producing rRNA appear to be situated at the periphery of the fibrillar centres.162-163 Within the NOR certain acidic non-histone proteins, mainly No 38 (B23) and nucleolin (C23)162,164-165 stain preferentially using a range of silver (Ag) impregnation techniques, and when the NOR's are visualised in this way, they are known as AgNOR's. With 5 chromosomal locations and 2 copies of each chromosome there are 10 NOR's in each normal human somatic cell, 20 after DNA replication prior to division. Nucleolin appears to stain only when rRNA is being produced166 so, during normal cell activity, only 1 or 2 AgNOR's can be demonstrated, although this number increases when the nucleoli dissociate during division.

The diagnostic significance of AGNOR'S
In tissue sections quantitative changes in the mean AgNOR count may occur when:167
A variety of analytical methods based on the number, size, morphology and distribution of AgNOR's in tissue sections165,167-169 have been proposed as indicators for assessing malignancy, tumour stage, differentiation, growth rate, invasion, recurrence and prognosis. Several video image analysis protocols have also been described.168,170 The full utility of AgNOR evaluation has yet to be established as, although standardised protocols for visualisation and analysis have been promoted,168-169 the range of methods currently in use makes comparison of data difficult. It is apparent however that AgNOR staining provides useful diagnostic information for a range of tumour types, 171 although in some instances there may be little or no benefit over established assessment methods.

Staining can be combined with standard chromosome banding techniques172-174 to identify chromosomal variants which allows the determination of:175
AgNOR staining techniques are also easily adapted for the identification of nuclear and nucleolar proteins after gel electrophoresis176 and in Western blots.177

The development of AGNOR staining techniques
The major problems associated with the visualisation (silver impregnation) and interpretation of AgNOR's in tissue sections are:178
Ammoniacal-silver solutions173,179-180 and simple aqueous silver nitrate solutions173 have been used to demonstrate AgNOR's but both methods are unreliable due to non-specific silver deposition.174 To reduce non-specific precipitates using the latter preparations the specimen is pre-incubated with saline sodium citrate solution and fine nylon mesh is used to both filter and cover the silver incubation medium (the salt-nylon technique).181-183 In addition, pre-treatment of specimens with Schiff's reagent182 or 0.0001 mol/l potassium cyanide has also been claimed to reduce background precipitates and increase stain specificity.184

Techniques for AGNOR demonstartion
Protocols in common use have evolved from the simplified, rapid, one-step method of Howell and Black.174 In this method specimens are incubated in a solution of silver nitrate, gelatin, and formic acid, the gelatin acting as a protective colloid which inhibits non-specific silver deposition.185. The most common modification186 performs the silver incubation step at 20-22°C (rather than 70°C). This protocol has been applied to smears and chromosome spreads as well as plastic and paraffin sections. As stain specificity decreases with prolonged treatment187 the length of incubation is critical (usually between 20-35 minutes165,168-169) and depends upon the tissue under investigation and the staining pattern required for AgNOR assessment. Additional strategies for the reduction of non-specific silver precipitates include the use of a developer containing 50% gum acacia in 1% formic acid (rather than gelatin-formic acid)170 as well as gold toning of stained sections, followed by gold reduction. The latter is claimed to improve the resolution of AgNORs by reducing their aggregation as well as decreasing background staining.188

Further improvements have been proposed which eliminate non-specific precipitates and increase specificity178 by: (a) reducing the specimens with 1% dithiothreitol (Cleland's reagent) before silver incubation; and (b) using a specific type of gelatin in the protective colloid. Permanency is improved by treating the specimens with sodium thiosulphate after silver staining (removing excess thiosulphate with thiosulphate remover), then gold toning.

Staining technique for the diagnostic assessment of AgNOR's178
SPECIMEN PREPARATION
AgNOR demonstration is compatible with routine fixatives (alcohol and formalin) and microwave fixation.178,189-190 Lead- and zinc-formalin have no effect or may improve staining slightly178 but Bouin's and Zenker's fixatives are less acceptable as they give a mild increase in background. Fixatives that contain mercury, or oxidants such as dichromate, are detrimental and not recommended. Glutaraldehyde also reduces reactivity.178,191 Air-dried smears are fixed in a mixture of 3:1 ethanol-acetic acid for 5 minutes.186

To optimise stain performance and subsequent specimen evaluation specimen preparation should be standardised and include: (a) paraffin sections of constant thickness (such as 3 µm); (b) fixation in buffered formalin for biopsies, fixation in methanol/formalin/acetic acid for cytology specimens, or acetone fixation (10 minutes at -20°C) for tissue cultures; (c) silver incubation at room temperature for approximately 30 minutes for paraffin sections and cytology specimens, or 20 minutes for cultured cells. In tissue sections, red blood cells (no AgNOR staining) and lymphocytes (usually one central AgNOR) act as internal controls.165

REAGENTS REQUIRED
1 Reducing solution (1% aqueous dithiothreitol)
Prepare just before use. Each slide requires approximately 0.2 ml of solution.
2 Silver stain
A Colloidal developer
2% gelatin in 1% formic acid.
Use only type B gelatin from bovine skin (lime-cured), 75 bloom. Requires 30 minutes to dissolve, do not heat. Filter before use.
B 50% aqueous silver nitrate solution
This can be made fresh or used as a stock solution (store in a clean bottle in the dark at 4oC).
C Working solution (silver stain solution)
Immediately before use mix 1 volume of developer (A) with 2 volumes of silver nitrate (B).
3 5% aqueous sodium thiosulphate
It is recommended that this solution be kept for no more than a few days (discard if a precipitate is present).
4 Sodium thiosulphate remover (Eastman-Kodak hypo eliminator solution HE-1) Prepare just before use. To make 50 ml add 0.5 ml of concentrated ammonium hydroxide to 42.25 ml of water. Immediately before use add 7.25 ml of 3% hydrogen peroxide.
5 Gold toner (Eastman-Kodak gold protective solution GP-1)
A 1% aqueous gold chloride.
Can be kept as a stock solution stored in the dark.
B Dissolve 0.5 g of sodium thiocyanate in 6.25 ml of water.
C Working solution
For use: dilute 0.5 ml of gold chloride stock solution in 43.25 ml of water. After mixing, add solution B (aqueous sodium thiocyanate) and mix again.

METHOD
This protocol is applicable to tissue sections (including archival material) and smears178 and should also be suitable for chromosome spreads with little or no modification.
1 Remove embedding material (resin or paraffin wax) and rehydrate sections.
2 Reduce specimen by incubating with 1% dithiothreitol for 10-30 minutes at room temperature (15 minutes is ideal for most specimens).
3 Rinse slide in several changes of water then shake off excess.
4 Pipette freshly mixed silver stain solution onto the slide and incubate (in the dark) at 23*C for 25-40 minutes.
Note: To achieve maximum reliability incubation is best carried out in a humid chamber with the temperature carefully controlled. The ideal incubation time must be determined for each specimen and depends upon the tissue type, fixation, and the staining pattern required.
5 Wash thoroughly in water.
6 Incubate with sodium thiosulphate for 5 minutes.
Note: prolonged immersion will cause bleaching.
7 Wash thoroughly in water.
Optional steps for archival preservation:
8 Immerse in sodium thiosulphate remover for 5 minutes.
9 Wash thoroughly in water.
10 Immerse in gold toner for a minimum of 5 minutes.
11 Wash thoroughly in water.
12 Counterstain, dehydrate, clear and mount.

RESULTS (Fig 9)
NOR's - black
In tissue sections NOR's are visible either as black dots within nucleoli (nucleolar NOR's), or dispersed in the nucleus (extranucleolar NOR's).

Fig 9 - AgNOR staining using the technique of Lindner.178 Formalin-fixed, paraffin-embedded normal human prostate. NOR's are visible as dense granules in both glandular and stromal cells. (photomicrograph courtesy of LE Lindner, Texas A&M University, health Science center)

TECHNICAL NOTES
1 The recommended counterstain is 0.01% safranin (CI 50240) for 1 minute. This produces weak transparent nuclear staining that does not interfere with AgNOR quantitation. After evaluation it is possible to re-stain sections using most techniques.
2 In all cases, water should be double distilled or filtered and deionised, and glassware should be acid cleaned.

SILVER PRECIPITATION
In addition to the use of purified water and acid clean glassware (including slides and coverslips), the following precautions help to reduce silver precipitates:
THE EFFECT OF ENZYMES
Pre-treatment with protease (for example trypsin and pronase) eliminates staining.192

THE EFFECT OF pH
The effect of pH on ammoniacal silver techniques is discussed by Lomholt and Toft193. In Lindner's protocol the pH is optimal using the recommended silver nitrate-developer mixture.178

SILVER REMOVAL
Silver may be removed from sections that are too heavily stained, or to facilitate subsequent staining protocols but care is required with bleaching as small AgNOR's may be removed. Sections are taken back to water and lightened by a brief treatment in a freshly prepared solution of equal parts of 3.75% aqueous potassium ferricyanide and 24% aqueous sodium thiosulphate. Alternatively, sections may be treated for approximately 15 seconds (at room temperature) with 1% aqueous periodic acid, followed by a wash with water. The process is monitored microscopically after applying a coverslip. Bleached sections can be stained with a dye of choice or silver staining repeated.194
References
1 Ross MH, Reith EJ, Romrell LJ. Histology: a text and atlas. 2nd ed. Baltimore: Williams and Wilkins. 1989
2 Oertel JE, Heffess CS, Oertel YC. Pancreas. In: Sternberg SS, ed. Histology for pathologists. New York: Raven Press. 1992
3 Dayal Y, O'Briain DS. The pathology of the pancreatic endocrine cells. In: DeLellis RA, ed. Diagnostic immunohistochemistry (Masson monographs in diagnostic pathology). New York: Masson Publishing. 1981
4 Bordi C. Endocrine pancreas. In: Spicer SS, ed. Histochemistry in pathological diagnosis. New York: Marcel Dekker. 1987
5 Cotran RS, Kumar V, Robbins SL. Robbins pathologic basis of disease. 4th ed. Philadelphia: WB Saunders. 1989
6 Larsson L-I, Grimelius L, Håkanson R, et al. Mixed endocrine pancreatic tumours producing several peptide hormones. Am J Pathol 1975; 79: 271-279
7 Larsson L-I. Endocrine pancreatic tumours. Human Path 1978; 9: 401-416
8 Carleton's histological technique. 5th ed. Drury RAB, Wallington EA, eds. Oxford: Oxford University Press. 1980
9 Levene C, Feng P. Critical staining of pancreatic alpha granules with phosphotungstic acid hematoxylin. Stain Technol 1964; 39: 39-44
10 Kito H, Hosoda S. Triple staining for simultaneous visualization of cell types in islet of Langerhans of pancreas: successive application of argyrophil, aldehyde-fuchsin and lead-haematoxylin stains in a single tissue section. J Histochem Cytochem 1977; 25: 1019-1020
11 Henderson DW, Papadimitriou JM, Coleman M. Ultrastructural appearances of tumours: diagnosis and classification of human neoplasia by electron microscopy. 2nd ed. Edinburgh: Churchill Livingstone. 1986
12 Gomori G. Aldehyde-fuchsin: a new stain for elastic tissue. Am J Clin Pathol 1950; 20: 665-666
13 Puchtler H, Meloan SN, Waldrop FS. Aldehyde-fuchsin: historical and chemical considerations. Histochemistry 1979; 60: 113-123
14 Proctor GB, Horobin RW. The aging of Gomori's aldehyde-fuchsin: the nature of the chemical changes and the chemical structures of the coloured components. Histochemistry 1983; 77: 255-267
15 Cole LJ, Nettleton GS. A histochemical investigation of the mechanism of aldehyde fuchsin staining of pancreatic B-cell granules. Histochem J 1988; 20: 635-641
16 Mowry RW, Longley JB, Emmel VM. Only aldehyde fuchsin made from pararosanilin stains pancreatic B cell granules and elastic fibers in unoxidized microsections: problems caused by mislabelling of certain basic fuchsins. Stain Technol 1980; 55: 91-103
17 Mowry RW. Selective staining of pancreatic beta-cell granules: evolution and present status. Arch Pathol Lab Med 1983; 107: 464-468
18 Lazarus SS, Barden H. Localization of aldehyde fuchsin and adenosine triphosphatase staining in pancreatic ß cells. J Histochem Cytochem 1961; 9: 628-629
19 Denffer H. Bindungsort und Bindungsmodus von Aldehydfuchsin in den B-Zellen des Inselapparates: histochemische und elektronenmikroskopische Untersuchungen. Histochemie 1973; 36: 97-113
20 Greenwell MV, Nettleton GS, Feldhoff RC. An investigation of aldehyde fuchsin staining of unoxidized insulin. Histochemistry 1983; 77: 473-483
21 Mowry RW. Aldehyde fuchsin staining, direct or after oxidation: Problems and remedies, with special reference to human pancreatic B cells, pituitaries, and elastic fibers. Stain Technol 1978; 53: 141-154
22 Scott HR. Rapid staining of beta cell granules in pancreatic islets. Stain Technol 1952; 27: 267-268
23 Buehner TS, Nettleton GS, Longley JB. Staining properties of aldehyde fuchsin analogs. J Histochem Cytochem 1979; 27: 782-787
24 Churukian CJ. Problems with aldehyde fuchsin staining. Histologic 1979; 9: 123
25 Halmi NS. Differentiation of two types of basophils in the adenohypophysis of the rat and the mouse. Stain Technol 1952; 27: 61-64
26 Grimelius L. A silver nitrate stain for a2 cells in human pancreatic islets. Acta Soc Med Ups 1968; 73: 243-270
27 Grimelius L, Wilander E. Silver stains in the study of endocrine cells of the gut and pancreas. Invest Cell Pathol 1980; 3: 3-12
28 Sheehan DC, Hrapchak BB. Theory and practice of histotechnology. 2nd ed. St Louis: CV Mosby. 1980
29 Hellerström C, Hellman B. Some aspects of silver impregnation of the islets of Langerhans in the rat. Acta Endocrinol 1960; 35: 518-532
30 Bussolati G, Capella C, Vassallo G, Solcia E. Histochemical and ultrastructural studies on pancreatic A cells: Evidence for glucagon and non-glucagon components of the a granule. Diabetologia 1971; 7: 181-188
31 Lundqvist M, Arnberg H, Candell J, Malmgren M, Wilander E, Grimelius L, Öberg K. Silver stains for identification of neuroendocrine cells: a study of the chemical background. Histochem J 1990; 22: 615-623
32 Brinn NT. Rapid metallic histological staining using the microwave oven. J Histotechnol 1983; 6: 125-129
33 Churukian CJ. Microwave modification of Pascual's argyrophil method. Histologic 1989; 19: 121-123
34 Staples TC, Grizzle WE. Effect of temperature on argyrophil impregnation: development of a high temperature rapid argyrophil procedure. Stain Technol 1987; 62: 41-49
35 Garvey W, Fathi A, Bigelow F, Carpenter B, Jimenez C. A new method for demonstrating argyrophil cells of the pancreas and intestines. Stain Technol 1989; 64: 87-91
36 Grimelius L. The argyrophil reaction in islet cells of adult human pancreas studied with a new silver nitrate procedure. Acta Soc Med Ups 1968; 73: 271-294
37 DeLellis RA. The endocrine system. In: Cotran RS, Kumar V, Robbins SL, ed. Robbins pathologic basis of disease. 4th ed. Philadelphia: WB Saunders. 1989
38 McKeever PE, Spicer SS. The pituitary: contributions of cytochemistry to pathological diagnosis. In: Spicer SS, ed. Histochemistry in pathological diagnosis. New York: Marcel Dekker. 1987
39 Phifer RF, Spicer SS, Hennigar GR. Human adenohypophyseal mucoid cell staining. Am J Pathol 1969; 55: 72a
40 Slidders W. The OFG and BrAB-OFG methods for staining the adenohypophysis. J Pathol Bacteriol 1961; 82: 532-534
41 Herlant M, Pasteels JL. Histophysiology of human anterior pituitary. Meth Achievm Exp Path 1967; 3: 250-305
42 Phifer RF, Spicer SS, Hennigar GR. Histochemical reactivity and staining properties of functionally defined cell types in the human adenohypophysis. Am J Pathol 1973; 73: 569-587
43 Pernicone PJ, Scheithauer BW, Horvath E, Kovacs K. Pituitary and sellar region. In: Sternberg SS, ed. Histology for pathologists. New York: Raven Press. 1992
44 Wilson POG, Chalk BT. The neuroendocrine system. In: Bancroft JD, Stevens A, ed. Theory and practice of histological technique. 3rd ed. Edinburgh: Churchill Livingstone, 1990
45 Pearse AGE. Histochemistry theoretical and applied. Vol 1. 3rd ed. London: J&A Churchill. 1968 46 Culling CFA. Miscellaneous staining procedures. In: Lynch's medical laboratory technology. Vol II. 3rd ed. Philadelphia: WB Saunders, 1976
47 Phifer RF, Spicer SS, Orth DN. Specific demonstration of the human hypophyseal cells which produce adrenocorticotropic hormone. J Clin Endocrinol Metab 1970; 31: 347-361
48 Kovacs K, Horvath E, Ryan N. Immunocytology of the human pituitary. In: DeLellis RA, ed. Diagnostic immunohistochemistry (Masson monographs in diagnostic pathology). New York: Masson Publishing. 1981
49 Taylor CR. Immunomicroscopy: a diagnostic tool for the surgical pathologist. Philadelphia: WB Saunders. 1986
50 Phifer RF, Midgley AR, Spicer SS. Immunohistochemical and histologic evidence that follicle-stimulating hormone and luteinizing hormone are present in the same cell type in the human pars distalis. J Clin Endocrinol Metab 1973; 36: 125-141
51 Phifer RF, Spicer SS. Immunohistochemical and histologic demonstration of thyrotropic cells of the human adenohypophysis. J Clin Endocrinol Metab 1973; 36: 1210-1221
52 Wheater PR, Burkitt HG, Daniels VG. Functional histology: a colour text and atlas. 2nd ed. Edinburgh: Churchill Livingstone. 1987
53 Mathan M, Hughes J, Whitehead R. The morphogenesis of the human Paneth cell: an immunocytochemical ultrastructural study. Histochemistry 1987; 87: 91-96 54 Rodning CB, Wilson ID, Erlandsen SL. Immunoglobulins within human small-intestinal Paneth cells. Lancet 1976; 1: 984-987
55 Bohe M, Borgström A, Lindström C, Ohlsson K. Trypsin-like immunoreactivity in human Paneth cells. Digestion 1984; 30: 271-275
56 Sandow MJ, Whitehead R. Progress report: the Paneth cell. Gut 1979; 20: 420-431
57 Bohane TD, Cutz E, Hamilton JR, Gall DG. Acrodermatitis enteropathica, zinc, and the Paneth cell: a case study report with family studies. Gastroenterology 1977; 73: 587-592
58 Watson PH. Fibrillary cytoplasmic inclusions in neoplastic Paneth cells. Histopathology 1990; 16: 69-74
59 Geller SA, Thung SN. Morphologic unity of Paneth cells. Arch Pathol Lab Med 1983; 107: 476-479
60 Lendrum AC. The phloxine-tartrazine method as a general histological stain and for the demonstration of inclusion bodies. J Path Bact 1947; 59: 399-404
61 Lewin K. Histochemical observations on Paneth cells. J Anat 1949; 105: 171-176
62 Subbuswamy SG. Paneth cells and goblet cells. J Path 1973; 111: 181-189
63 Bancroft JD, Stevens A. Theory and practice of histological techniques. 3rd ed. Edinburgh: Churchill Livingstone. 1990
64 Bartholomew JW. Stains for microorganisms in sections. In: Clark C, ed. Staining procedures. 4th ed. Baltimore: Williams and Wilkins. 1981
65 Martinez-Madrigal F, Micheau C. Major salivary glands. In: Sternberg SS, ed. Histology for pathologists. New York: Raven Press, 1992
66 Lillie RD, Fullmer HM. Histopathologic technic and practical histochemistry. 4th ed. New York: McGraw-Hill. 1976
67 Galli SJ. Biology of disease. New insights into "The riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990; 62: 5-33
68 Enerbäck L. Mast cells. In: Spicer SS, ed. Histochemistry in pathologic diagnosis. New York: Marcel Dekker. 1987
69 Yam LT, Li CY, Crosby WH. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 1971; 55: 283-290
70 Befus AD, Dyck N, Goodacre R, Bienenstock J. Mast cells from the human intestinal lamina propria: isolation, histochemical subtypes, and functional characterization. J Immunol 1987; 138: 2604-2610
71 Holgate ST. Defence mechanisms: Basophil polymorph and mast cells. In: McGee J O'D, Isaacson PG, Wright NA, eds. Oxford textbook of pathology, Vol 1, Principles of pathology. Oxford: Oxford University Press. 1992
72 Enerbäck L. Mast cells in rat gastrointestinal mucosa: I Effects of fixation. II Dye-binding and metachromatic properties. Acta Pathol Microbiol Scand 1966; 66: 289-312
73 Strobel S, Miller HRP, Ferguson A. Human intestinal mucosa mast cells: evaluation of fixation and staining techniques. J Clin Pathol 1981; 34: 851-858
74 Wingren U, Enerbäck L. Mucosal mast cells of the rat intestine: a re-evaluation of fixation and staining properties, with special reference to protein blocking and solubility of the granular glycosaminoglycan. Histochem J 1983; 15: 571-582
75 Pipkorn U, Karlsson G, Enerbäck L. Phenotypic expression of proteoglycan in mast cells of the human nasal mucosa. Histochem J 1988; 20: 519-525
76 Murphy GF, Mihm MC. The Skin. In: Cotran RS, Kumar V, Robbins SL, eds. Robbins pathologic basis of disease. 4th ed. Philadelphia: WB Saunders. 1989
77 Churukian CJ, Schenk EA. A toluidine blue method for demonstrating mast cells. J Histotechnol 1981; 4: 85-86
78 Tarpley JE, Meschter CL, Tyler DE. Modified congo red - acidified toluidine blue stain: a new technique for the simultaneous specific staining of eosinophils and mast cells in paraffin tissue sections. J Histotechnol 1984; 7: 141-142
79 McKenna MJ, Lundin D, Villanueva AR, Parfitt AM. Comparison of methods for staining mast cells in undecalcified sections of bone. J Histotechnol 1990; 13: 49-51
80 Gomori G. Chloroacyl esters as histochemical substrates. J Histochem Cytochem 1953; 1: 469-470
81 Moloney WC, McPherson K, Fliegelman L. Esterase activity in leukocytes demonstrated by the use of naphthol AS-D chloroacetate substrate. J Histochem Cytochem 1960; 8: 200-207
82 Leder LD. Über die selektive fermentcytochemische Darstellung von neutrophilen myeloischen Zellen und Gewebsmastzellen im Paraffinschnitt. Klin Wochenschr 1964; 42: 553
83 Stevens A. Enzyme histochemistry: Diagnostic applications. In: Bancroft JD, Stevens A, eds. Theory and practice of histological techniques. 3rd ed. Edinburgh: Churchill Livingstone. 1990
84 Leder LD, Stutte HJ. Seminar für hämatologisch-zytochemische Techniken. Verh Dtsch Ges Pathol 1975; 59: 503-509
85 Shaw ST, Roche PC, Schmer G. Macaulay LK. Immunohistochemical identification of mast cells in paraffin and Epon-embedded tissues using platelet factor 4. J Histochem Cytochem 1982; 30: 185-188
86 Johansson O, Virtanen M, Hilliges M, Yang Q. Histamine immunohistochemistry: a new and highly sensitive method for studying cutaneous mast cells. Histochem J 1992; 24: 283-287
87 Roberts ISD, Jones CJP, Stoddart RW. Lectin histochemistry of the mast cell: heterogeneity of rodent and human mast cell populations. Histochem J 1990; 22: 73-80
88 Baker JR. Principles of biological microtechnique: a study of fixation and dyeing. London: Methuen. 1958
89 Cramer AD, Rogers ER, Parker JW, Lukes RJ. The Giemsa stain for tissue sections: an improved method. Am J Clin Pathol 1973; 59: 148-156
90 Lillie RD. HJ Conn's biological stains, 9th ed. Baltimore: Williams and Wilkins. 1977
91 Power KT. The Romanowsky stains: a review. Am J Med Technol 1982; 48: 519-523
92 Boon ME, Drijver JS. Routine cytological staining techniques: theoretical background and practice. Hampshire: Macmillan Education. 1986
93 Wittekind DH, Kretschmer V, Sohmer I. Azure B-eosin Y stain as the standard Romanowsky-Giemsa stain. Br J Haematol 1982; 51: 391-393
94 Block M. Bone marrow examination: aspiration or core biopsy, smear or section, hematoxylin-eosin or Romanowsky stain - which combination? Arch Pathol Lab Med 1976; 100: 454-456
95 Wickramasinghe, SN. Bone marrow. In: Sternberg SS, ed. Histology for pathologists. New York: Raven Press. 1992
96 Lennert K, Feller AC. Histopathology of non-Hodgkin's lymphoma. 2nd ed. Berlin: Springer-Verlag, 1992. Soehring M, translator.
97 Boon ME, Kok LP, Moorlag HE, Gerrits PO, Suurmeijer AJH. Microwave-stimulated staining of plastic embedded bone marrow sections with the Romanowsky-Giemsa stain: improved staining patterns. Stain Technol 1987; 62: 257-266
98 Wittekind D, Schulte E, Schmidt G, Frank G. The standard Romanowsky-Giemsa stain in histology. Biotech Histochem 1991; 66: 282-295
99 Inwood MJ, Thomson S. Basic hematologic techniques. In: Lynch's medical laboratory technology, Vol II, 3rd ed. Philadelphia: WB Saunders. 1976
100 Wittekind DH. On the nature of Romanowsky-Giemsa staining and its significance for cytochemistry and histochemistry: an overall view. Histochem J 1983; 15: 1029-1047
101 Bancroft JD, Stevens A. Theory and practice of histological techniques, 1st ed. Edinburgh: Churchill Livingstone. 1977
102 Horobin RW, Boon ME. Understanding microwave-stimulated Romanowsky-Giemsa staining of plastic embedded bone marrow. Histochem J 1988; 20: 329-334
103 Clarke JD. A 24-hour bone marrow biopsy preparation method. Aust J Med Lab Sci 1991; 12: 138-141
104 Schulte E. Standardization of the Romanowsky-Giemsa stain: the influence of staining time on the RG-staining pattern. Acta Histochem Suppl 1987; 34: 153-162
105 ICSH reference method for staining of blood and bone marrow films by azure B and eosin Y (Romanowsky stain). Br J Haematol 1984; 57: 707-710
106 O'Connell R, Lower D, Errington G, Llewellyn J. Factors influencing the Romanowsky effect. Aust J Med Lab Sci 1982; 3: 125-139
107 Rhodin JAG. Histology. A text and atlas. New York: Oxford University Press. 1974
108 Wheater PR, Burkitt HG, Stevens A, Lowe JS. Basic histopathology. A colour atlas and text. Edinburgh: Churchill Livingstone. 1985
109 Papadimitriou JM, Henderson DW, Spagnolo DV. Diagnostic ultrastructure of non-neoplastic diseases. Edinburgh: Churchill Livingstone. 1992
110 Lake BD. Applications of enzyme histochemistry in pathological diagnosis. In: Stoward PJ, Pearse AGE, eds. Histochemistry, theoretical and applied. Vol 3, 4th ed. Edinburgh: Churchill Livingstone. 1991
111 Johnson LV, Walsh ML, Chen LB. Localization of mitochondria in living cells with rhodamine 123. Proc Natl Acad Sci USA 1980; 77: 990-994
112 Schwind JL. The supravital method in the study of the cytology of blood and marrow cells. Blood 1950; 5: 597-622
113 Hetherington DC. Pinacyanol as a supra-vital mitochondrial stain for blood. Stain Technol 1936; 11: 153-154
114 Crawford JM, Braunwald NS. Toxicity in vital fluorescence microscopy: effect of dimethylsulfoxide, rhodamine-123, and DiI-low density lipoprotein on fibroblast growth in vitro. In Vitro Cell Dev Biol 1991; 27A: 633-638
115 Altmann R. Die elementarorganismen 2nd ed. Liepsig. 1894
116 Scheuer PJ. Liver biopsy interpretation. 3rd ed. London: Baillière Tindall. 1980
117 Golgi C. Sur la structure des cellules nerveuses. Arch Ital Biol 1898; 30: 61-71
118 Golgi C. Sur la structure des cellules nerveuses des ganglions spinaux. Arch Ital Biol 1898; 30: 278-286
119 Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Molecular biology of the cell, 2nd ed. New York: Garland Publishing. 1989
120 Ghadially FN. Ultrastructural pathology of the cell and matrix. Vol 1. 3rd ed. London: Butterworths. 1988
121 Barrett AJ, Heath MF. Lysosomal enzymes. In: Dingle JT, ed. Lysosomes: a laboratory handbook. 2nd ed. Amsterdam: North Holland Biomedical Press. 1977
122 Ghadially FN. Ultrastructural pathology of the cell and matrix. Vol 2. 3rd ed. London: Butterworths. 1988
123 Dingle JT, editor. Lysosomes: a laboratory handbook. 2nd ed. Amsterdam: North Holland Biomedical Press. 1977
124 Allison AC, Young MR. Vital staining and fluorescence microscopy of lysosomes. In: Lysosomes in biology and pathology. Dingle JT, Fell HB, eds. Vol 2. Amsterdam: North Holland Publishing. 1969
125 Poole AR. The detection of lysosomes by vital staining with acridine orange. In: Dingle JT, ed. Lysosomes: a laboratory handbook. 2nd ed. Amsterdam: North Holland Biomedical Press. 1977
126 Osborn M, Weber K. Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest 1983; 48: 372-394
127 Baden HP. The keratinocyte has become the subject of intensive investigation. J Invest Dermatol 1984; 82: 305-307
128 Mallory FB. Cirrhosis of the liver. Five different types of lesions from which it may arise. Bulletin of Johns Hopkins Hospital 1911; 22: 69-75
129 Hall P de la M. Alcoholic liver disease. In: MacSween RNM, Anthony PP, Scheuer PJ, eds. Pathology of the liver, 2nd edition. Edinburgh, Churchill Livingstone. 1987
130 Kusama H, Takizawa N. A case of lung cancer with Mallory bodies. Rinsho Byori 1992; 40: 210-214
131 Ohta M, Marceau N, Perry G, Manetto V, Gambetti P, Autilio-Gambetti L. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Lab Invest 1988; 59: 848-856
132 Zatloukal K, Spurej G, Rainer I, Lackinger E, Denk H. Fate of Mallory body-containing hepatocytes: disappearance of Mallory bodies and restoration of the hepatocytic intermediate filament cytoskeleton after drug withdrawal in the griseofulvin-treated mouse. Hepatol 1990; 11: 652-661
133 Preisegger KH, Zatloukal K, Spurej G, Denk H. Changes of cytokeratin filament organization in human and murine Mallory body-containing livers as revealed by a panel of monoclonal antibodies. Liver 1991; 11: 300-309
134 Van Eyken P, Sciot R, Desmet VJ. A cytokeratin immunohistochemical study of alcoholic liver disease: evidence that hepatocytes can express "bile duct type" cytokeratins. Histopathology 1988; 13: 605-617
135 Zatloukal K, Denk H, Spurej G, Lackinger E, Preisegger KH, Franke WW. High molecular weight component of Mallory bodies detected by a monoclonal antibody. Lab Invest 1990; 62: 427-434
136 Leevy CB, Sameshima Y, Yoshioka K, Leevy CM, Kanagasundaram N, Unoura M. Use of a specific monoclonal antibody to detect Mallory bodies in liver disease. J Assoc Acad Minor Phys 1990; 1: 24-30
137 Hoso M, Nakanuma Y. Cytomorphometric DNA analysis of hepatocellular carcinoma with Mallory bodies. Virchows Arch A Pathol Anat Histopathol 1989; 416: 51-55
138 Yokoo H, Minick OT, Batti F, Kent G. Morphologic variants of alcoholic hyalin. Am J Pathol 1972; 69: 25-40
139 Issidorides MR, Panayotacopoulou MT, Tiniacos G. Similarities between neuronal Lewy bodies in Parkinsonism and hepatic Mallory bodies in alcoholism. Pathol Res Pract 1990; 186: 473-478
140 Wessely Z, Shapiro SH, Klavins JV, Tinberg HM. Identification of Mallory bodies with rhodamine B fluorescence and other stains for keratin. Stain Technol 1981; 56: 169-176
141 Yoshioka K, Kakuma S, Tahara H, Arao M, Fuji A, Hirofuji H, Hayashi T, Kano H. Occurrence of immunohistochemically detected small Mallory bodies in liver disease. Am J Gastroenterol 1989; 84: 535-539
142 Russell W. An address on a characteristic organism of cancer. Br Med J 1890; 2: 1356-1360
143 Bessis M. Living blood cells and their ultrastructure. Berlin: Springer-Verlag. 1976
144 Hyun BH, Kwa D, Gabaldon H, Ashton JK. Reactive plasmacytic lesions of the bone marrow. Am J Clin Pathol 1976; 65: 921-928
145 Schweitzer PA, Taylor SE, Shultz LD. Synthesis of abnormal immunoglobulins by hybridomas from autoimmune "viable motheaten" mutant mice. J Cell Biol 1991; 114: 35-43
146 Shultz LD, Coman DR, Lyons BL, Sidman CL, Taylor S. Development of plasmacytoid cells with Russell bodies in autoimmune "viable motheaten" mice. Am J Pathol 1987; 127: 38-50
147 Maldonado JE, Brown AL, Bayrd ED, Pease GL. Cytoplasmic and intranuclear electron-dense bodies in the myeloma cell. Light and electron microscopy observations. Arch Pathol 1966; 81: 484-500
148 El-Okda M, Ko YH, Xie S-S, Hsu S-M. Russell bodies consist of heterogenous glycoproteins in B-cell lymphoma cells. Am J Clin Pathol 1992; 97: 866-871 149 Mott FW. Observations on the brains of men and animals infected with various forms of trypanosomes: preliminary note. Proc R Soc 1905; 76: 235-242
150 Zucker-Franklin D. Multiple myeloma. II. Structural features of cells associated with the paraproteinias. Semin Hematol 1964; 1: 165-198
151 Weinstein T, Mittelman M, Djaldetti M. Electron microscopy study of Mott and Russell bodies in myeloma cells. J Submicrosc Cytol 1987; 19: 155-159
152 Kindred JE. Reactions of hemoglobiniferous cells to acid and basic dyes under varying conditions of H-ion activity. Stain Technol 1935; 10: 7-20
153 Brunning RD, Parkin J. Intranuclear inclusions in plasma cells and lymphocytes from patients with monoclonal gammopathies. Am J Clin Pathol 1976; 60: 10-21
154 Dutcher T, Fahey J. The histopathology of the macroglobulinemia of Waldenstrom. J Natl Cancer Inst 1959; 22: 887-917
155 Van Den Tweel JG, Taylor CR, Parker JW, Lukes RJ. Immunoglobulin inclusions in Non-Hodgkin's Lymphomas. Am J Clin Pathol 1978; 69: 306-313
156 Tarlington D, Forster I, Rajewsky K. An explanation for the defect in secretion of IgM Mott cells and their predominant occurrence in the Ly-1 B cell compartment. Eur J Immunol 1992; 22: 531-539
157 Fisher ER, Zawadski ZA. Ultrastructural features of plasma cells in patients with paraproteinemias. Am J Clin Pathol 1970; 54: 779-789
158 Scroggs MW, Roggli VL, Fraire AE, Sanfilippo F. Eosinophilic intracytoplasmic globules in pulmonary adenocarcinomas: a histochemical, immunohistochemical, and ultrastructural study of six cases. Hum Pathol 1989; 20: 845-849
159 Bangle R. A morphologic and histochemical study of cytoplasmic Russell bodies in cancer cells. Am J Pathol 1963; 43: 437-448
160 Welsh RA. Light and electron microscopic correlation of the periodic acid-schiff reaction in the human plasma cell. Am J Pathol 1962; 40: 285-296
161 Goldberg AF, Deane HW. Staining properties of Russell bodies and crystals in plasmocytes in comparison with amyloid. J Histochem Cytochem 1960; 8: 327-328
162 Derenzini M, Thiry M, Goessens G. Ultrastructural cytochemistry of the mammalian cell nucleolus. J Histochem Cytochem 1990; 38: 1237-1256
163 Motte PM, Loppes R, Menager M, Deltour R. Three-dimensional electron microscopy of ribosomal chromatin in two higher plants: a cytochemical, immunocytochemical, and in situ hybridization approach. J Histochem Cytochem 1991; 39: 1495-1506
164 Lischwe MA, Smetana K, Olson MOJ, Busch H. Proteins C23 and B23 are the major nucleolar silver staining proteins. Life Sci 1979; 25: 701-708
165 Plate KH, Rüschoff J, Mennel HD. Application of the AgNOR technique to neurooncology. Acta Histochem 1992; Suppl.-Band XLII, S: 171-178
166 Miller OJ, Miller DA, Dev VG, Tantrahavi R, Croce CM. Expression of human and suppression of mouse nucleolus organizer activity in mouse-human somatic cell hybrids. Proc Natl Acad Sci USA 1976; 73: 4531-4555
167 Underwood JCE, Giri DD. Nucleolar organizer regions as diagnostic discriminants for malignancy. J Pathol 1988; 155: 95-96
168 Rüschoff J, Plate KH, Contractor H, Kern S, Zimmerman R, Thomas C. Evaluation of nucleolus organizer regions (NORs) by automatic image analysis: a contribution to standardization. J Pathol 1990; 161: 113-118
169 Crocker J, Boldy DAR, Egan MJ. How should we count AgNORS? Proposals for a standardized approach. J Pathol 1989; 158: 185-188
170 Weeks SC, Beroukas D, Jarvis LR, Whitehead R. Video image analysis of AgNOR distribution in the normal and adenomatous colorectum. J Pathol 1992; 166: 139-145
171 Editorial. NORs-A new method for the pathologist. Lancet 1987; 1: 1413-1414
172 Tuck-Miller CM, Bordson BL, Kane MM, Hamilton AE. A method for combined C-banding and silver staining. Stain Technol 1984; 59: 265-268
173 Bloom SE, Goodpasture C. An improved technique for selective silver staining of nucleolar organizer regions in human chromosomes. Hum Genet 1976; 34: 199-206
174 Howell WM, Black DA. Controlled silver-staining of nucleolar organizer regions with a protective colloid developer: a 1-step method. Experientia 1980; 36: 1014-1015
175 Martin AO. Silver staining in clinical cytogenetics. Stain Technol 1985; 60: 275-284
176 Williams MA, Kleinschmidt JA, Krohne G, Franke WW. Argyrophilic nuclear and nucleolar proteins of Xenopus laevis oocytes identified by gel electrophoresis. Exp Cell Res 1982; 137: 341-351
177 Hozak P, Roussel P, Hernandez-Verdun D. Procedures for specific detection of silver-stained nucleolar proteins on Western blots. J Histochem Cytochem 1992; 40: 1089-1096
178 Lindner LE. Improvements in the silver-staining technique for nucleolar organizer regions (AgNOR). J Histochem Cytochem 1993, 41: 439-445
179 Howell WM, Denton TE, Diamond JR. Differential staining of the satellite regions of human acrocentric chromosomes. Experientia 1975; 31: 260-262
180 Goodpasture C, Bloom SE. Visualization of nucleolar organizer regions in mammalian chromosomes using silver staining. Chromosoma 1975; 53: 37-50
181 Stack S, Herickhoff L, Sherman J, Anderson L. Staining plant cells with silver. 1. The salt-nylon technique. Biotech Histochem 1991; 66: 69-78
182 Thiebaut F, Rigaut SP, Reith A. Improvement in the specificity of the silver staining technique for AgNOR-associated acidic proteins in paraffin sections. Stain Technol. 1984; 59: 181-185
183 Kodama Y, Yoshida MD, Motomichi S. An improved silver staining technique for nucleolus organizer regions by using nylon cloth. Jpn J Hum Genet 1980; 25: 229-233
184 Ferraro M, Lavia P, Pellicia F, DeCapoa A. Effects of potassium cyanide on silver stainability of specific cell structures. Stain Technol 1982; 57: 259-263
185 Scopsi L. Silver-enhanced colloidal gold method. In: Hayat MA, ed. Colloidal gold. Principles, methods, and applications, Vol 1. San Diego: Academic Press. 1989
186 Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 1986; 18: 5-14
187 Hubbell HR. Silver staining as an indicator of active ribosomal genes. Stain Technol 1985; 60: 285-294
188 Delahunt B, Avallone FA, Ribas JL, Mostofi FK. Gold toning improves the visualization of nucleolar organizer regions in paraffin embedded tissues. Biotech Histochem 1991; 66: 316-320
189 Leong AS-Y, Gilham P. Silver staining of nucleolar organizer regions in malignant melanoma and melanotic nevi. Hum Pathol 1989; 20: 257-262
190 Leong AS-Y, Raymond WA. Demonstration of AgNOR-related proteins in microwave-fixed tissues. J Pathol 1988; 156: 352
191 Smith PJ, Skilbeck N, Harrison A, Crocker J. The effect of a series of fixatives on the AgNOR technique. J Pathol 1988; 155: 109-112 192 Brat SV, Verma RS, Dosik H. A simplified technique for simultaneous staining of nucleolar organizer regions and kinetochores. Stain Technol 1979; 54: 107-108
193 Lomholt BE, Toft JM. The effect of pH on silver staining of nucleolus organizer regions. Stain Technol 1987; 62: 101-105
194 Denton TE. A rapid method for removing silver from stained chromosomes. Stain Technol 1989; 64: 49-52
Safety Data - Special Tissues